Dr. Chris Slatore CV

CURRICULUM VITAE

OREGON HEALTH & SCIENCE UNIVERSITY

Christopher G. Slatore, MD MS March 25, 2024

Present Position & Office Address

Investigator

Center to Improve Veteran Involvement in Care (CIVIC)

Health Services Research & Development

VA Portland Health Care System (VAPORHCS)

3710 SW US Veterans Hospital Road

Portland, OR 97239-2964

And

Professor, Department of Medicine

Division of Pulmonary, Allergy, & Critical Care Medicine

And

Adjunct Research Professor, Department of Radiation Medicine

Oregon Health & Science University

3181 SW Sam Jackson Park Road

Mail Code UHN67

Portland, OR 97239-3098

Christopher.slatore@va.gov or slatore@ohsu.edu

II. EDUCATION

1989-1993 Bachelor of Arts in Biology; English minor

University of Oregon; Eugene, Oregon

1997-2001 Doctor of Medicine

University of Washington School of Medicine; Seattle, Washington

2004-2008 Masters of Science in Epidemiology

University of Washington School of Public Health; Seattle, Washington

POST-GRADUATE TRAINING

1. Internal Medicine Resident; Department of Medicine, University of Washington; Seattle, WA

1. Chief Medicine Resident; Department of Medicine, University of Washington; Seattle, WA

2005-2008 Senior Fellow; Division of Pulmonary and Critical Care Medicine, University of Washington; Seattle, WA

2008-2009 Senior Fellow/Acting Instructor; Division of Pulmonary and Critical Care Medicine, University of Washington; Seattle, WA

2015-2016 Fellow; Mentored Training in Dissemination & Implementation Research in Cancer, Washington University in St. Louis; sponsored by the National Cancer Institute (1 R25 CA171994-01A1)

BOARD CERTIFICATION

2007-Present Diplomat, American Board of Internal Medicine; Pulmonary Medicine

2008-Present Diplomat, American Board of Internal Medicine; Critical Care Medicine

2004-2014 Diplomat, American Board of Internal Medicine; Internal Medicine

PROFESSIONAL LICENSE

2001-Present Washington State Medical License: MD 00044046

III. PROFESSIONAL EXPERIENCE

FACULTY POSITIONS

2009 - 2015 Oregon Health & Science University Department of Medicine; Division of Pulmonary and Critical Care Medicine; Assistant Professor

2013 - 2015 Oregon Health & Science University Department of Medicine; Department of Radiation Medicine; Adjunct Assistant Research Professor

2015 - 2021 Oregon Health & Science University Department of Medicine; Division of Pulmonary and Critical Care Medicine; Associate Professor

2015 - 2021 Oregon Health & Science University Department of Medicine; Department of Radiation Medicine; Adjunct Associate Research Professor

2021 - Present Oregon Health & Science University Department of Medicine; Division of Pulmonary and Critical Care Medicine; Professor

2021 - Present Oregon Health & Science University Department of Medicine; Department of Radiation Medicine; Adjunct Research Professor

HOSPITAL POSITIONS

Pulmonary & Critical Care Medicine; Physician

Seattle Cancer Care Alliance 2008 - 2009

Pulmonary & Critical Care Medicine; Physician

VA Portland Health Care System 2009 - Present

CURRENT LEADERSHIP POSITIONS (Bold = Allocated FTE)

VA Portland Health Care System Lung Cancer Screening Program, Co-Director

VA Portland Health Care System 2015 - Present

Mark E. Deffebach Veterans Integrated Service Network 20 Centralized Lung Cancer Screening Program, Director

Veterans Integrated Service Networks 20 2020 - Present

National Center for Lung Cancer Screening, Chief Consultant

Veterans Health Administration 2021 - Present

OHSU Division of Pulmonary, Allergy, & Critical Care Medicine T32 Grant, Co-Director

Oregon Health & Science University 2021 - Present

Thoracic Oncology Assembly; Assembly Committee Chair-Elect & Chair

American Thoracic Society 2022 - Present

HONORS & AWARDS

2012 Early Career Investigator Award; American Thoracic Society, Behavioral Sciences & Health Services Research Assembly

2015 Speaker, Oregon Health & Science University Promotion and Tenure Celebration

2017 Eminent Reviewer of the Annals of the American Thoracic Society

2020 Nominated for OHSU Mid-Career Leadership Program

IV. SCHOLARSHIP

Area of Interest: I am interested in issues of prevention, detection, treatment, and healthcare delivery for patients with, and at risk for, tobacco-related lung diseases, chiefly lung cancer and chronic obstructive pulmonary disease (COPD). My primary research focus centers on improving patient outcomes and developing innovative treatment approaches in these areas. Through the application of comparative research methodologies, I hope to improve healthcare quality for patients with tobacco-related lung diseases.

Grants and Contracts

CURRENT RESEARCH FUNDING

Principal Investigator

IIR 19-425 Slatore (PI) 10/01/20 – 09/30/24

Teachable Moment to Opt-Out of Tobacco (TeaM OUT): A Stepped Wedge Cluster Randomized Trial

This project will evaluate whether a pragmatic, proactive, low-cost solution, that takes advantage of a naturally occurring teachable moment, can increase smoking abstinence in this group as well as provide generalizable results for patients in multiple settings and situations

Role: PI Source: Dept. of Veterans Affairs; HSRD Funding: $1,196,763

Other than Principal Investigator

1R01CA258464 (NCI) Heintzman (PI) 05/1/2022 - 4/30/2026

FRONTIERS: Foreign Born Latinos Cancer Screening.

This study proposes to evaluate the primary and secondary prevention of cancer in foreign-born Latinos seen in community health centers.

Role: Co-I Source: NIH; NCI Funding: $2,335,888 (total)

MRF New Investigator Grant Sullivan (PI) 09/01/2020-08/31/2025

Improving Decision Making in All Stage Lung Cancer (I DESCide): A Conversation Tool Among Patients Making Treatment Decisions.

The purpose of this randomized control trial is to test the effectiveness of a decision aid among patients making lung cancer treatment-related decisions in clinical settings.

Role: Co-I Source: Medical Research Foundation Funding: $50,000 (total)

NIH R01 CA249506 Braithwaithe (PI) 01/01/2020-12/31/2024

Precision screening for lung cancer: importance of comorbid conditions to clinical practice and policy

The goal of this study is to precisely characterize this vulnerable subpopulation with high comorbidity burden, quantifying for them the benefits and harms of LCS to enable more informed decision-making by patients contemplating LCS.

Role: Co-I Source: NIH; NCI Funding: $152,898/yr (Local)

VHA ORH RSS pilot Bailey (PI) 10/01/2022-09/30/2023

Smoking Cessation and Elective Surgery among Rural Veterans

This project aims to introduce an intervention that will aid rural Veterans seeking elective surgery in accessing smoking cessation resources.

Role: Co-I Source: VHA ORH Funding: $173,019

PCS-1403-12653 Gould (PI) 06/01/15-05/31/23

Pragmatic Trial of More versus Less Intensive Strategies for Active Surveillance of Patients with Small Pulmonary Nodules

The goal of this study is to compare two protocols for CT surveillance, both of which are supported by existing guidelines from professional societies and are consistent with current standards of care.

Role: Site PI Source: PCORI Funding: $14,458,936 (Site: $90,000/yr)

Mentored Awards

1 IK2 CX002049-01 Thompson (PI) 01/01/20-12/31/24

Quantifying and improving radiotherapy outcomes among Veterans

This proposal is a mentored VA Career Development Award to investigate genetic risk factors of radiation-induced secondary malignancy and second cancers more generally.

Role: Co-Mentor Source: VA CSRD Funding: $1,976,903

VA HSR&D CDA-2 18-191 Vranas (PI) 07/01/2020-6/30/2024

Optimizing Critical Care for Patients with Acute Respiratory Failure: A Mixed-Methods Study

The goal of this study is to investigate how the organizational characteristics and processes of care at Emergency Departments and Intensive Care Units impact the care of patients with diagnoses common in the ICU. We compare outcomes at high-acuity and low-acuity hospitals.

Role: Primary Mentor Source: Deparment of Veterans Affairs HSRD Funding: $1,193,989

VISN21 ECAP Rustagi (PI) 10/1/2023-9/30/2025

Veterans, clinicians, and the VA need detailed estimates of the risks/benefits of lung cancer screening, tailored to individual health status to prevent unnecessary harms. To address this critical knowledge gap, this project will quantify the risk of procedural complications by baseline health and emulate a randomized trial using observational data from Veterans to examine how baseline health affects the effectiveness of LCS.

Role: Co-Mentor Source. VISN21 Funding $180,000/year

PENDING RESEARCH FUNDING

PAST FUNDING

Principal Investigator

RVR 19-481 Slatore (PI) 07/01/19-06/30/22

Patient-Centered Decision Support for Veterans Making Choices About Where to Get Their Health Care: “Should I Stay or Should I Go?”

The goal of this study is to evaluate how Veterans to make decisions regarding receiving VHA vs. non-VHA care.

Role: Co-PI Source: Department of Veteran Affairs; HSRD Funding: $200,000

2019-CCSG-28 Slatore (PI) 09/01/19-06/30/20

Lung Cancer Screening Implementation in Rural Oregon: A Primary Care Provider Perspective

The goal of this study is to understand barriers and facilitators to implementation of high-quality lung cancer screening programs in rural and small practices in Oregon.

Role: PI Source: OHSU Knight Cancer Institute Funding: $40,000

4521018 Slatore (PI) 01/01/19-06/30/20

Pulmonary Nodule Prediction: A Radiomics & Machine-Learning Approach with a Pragmatic Focus

The goal of this study is to establish pulmonary nodule registries from two geographically distinct Department of Veterans Affairs health care systems to develop a deep learning-based model of lung cancer risk.

Role: PI Source: OHSU Knight Cancer Institute; CEDAR Funding: $110,000

128737-RSG-15-155-01-CPPB Slatore (PI) 01/01/16-12/31/19

Lung Cancer Screening Implementation: Evaluation of Patient-Centered Care

The goal of this study is to evaluate patient-centered outcomes among Veterans considering and undergoing lung cancer screening.

Role: PI Source: American Cancer Society Funding: $785,000

2018-CCSG-12 Slatore (PI) 08/01/18-07/31/19

Lung Cancer Screening Implementation: Key Informant Interview Study of Oregon’s Small and Rural Hospitals

The goal of this study is to understand barriers and facilitators to implementation of high-quality lung cancer screening programs in rural and small hospitals in Oregon.

Role: PI Source: OHSU Knight Cancer Institute Funding: $25,000

VAPORHCS CIVIC LIP Slatore (PI) 05/01/18-12/31/18

Barriers and Facilitators to a Consolidative Cancer Screening Program

The goal of this study is to use an implementation framework to better understand the perceived barriers and facilitators of widespread implementation of a consolidative cancer screening program.

Role: PI Source: Department of Veterans Affairs CIVIC Funding: $19,750

CSRD EPID-007-15S & HSRD IIR 16-003 Slatore (PI) 01/01/16-12/31/18

Lung Cancer Screening Implementation: Building Blocks for Effective Implementation & Partnership

The goal of this study is to develop a validate model of lung cancer risk among patients with pulmonary nodules and a model to identify these patients in administrative databases.

Role: PI Source: Department of Veterans Affairs CSRD & HSRD Funding: $440,000

ROI2013-915 Slatore (PI) 01/01/14-12/31/16

Radiation Therapy & Patient-Centered Outcomes among Lung Cancer Patients

The goal of this study is to evaluate patient-centered outcomes among patients with early stage lung cancer who are considering therapy.

Role: PI Source: Radiation Oncology Institute Funding: $200,000

CDA 09-025 & CDP 11-227 Slatore (PI) 02/01/11-9/30/15

Lung Cancer Evaluation: Association between Communication & Health

The goal of this study is to evaluate the psychosocial consequences of the lung cancer evaluation process with an emphasis on studying how patient-centered communication is assocated with these outcome

Role: PI Source: Department of Veterans Affairs HSR&D Funding: $166,000/yr

SB-164388-N Slatore (PI) 07/01/10-06/01/14

Depression and Lung Cancer: Association with Mortality and Processes of Care

The goal of this study is to evalute the association of depression with mortality and other health outcomes among patients with lung cancer.

Role: PI Source: American Lung Association Funding: $80,000

2008 Lung Cancer Award Slatore (PI) 07/01/08-06/30/10

Association of Hormone Replacement Therapy with Lung Cancer: a Cohort Study

The goal of this study was to evaluate the association of hormone replacement therapy with incident lung cancer.

Role: PI Source: CHEST Foundation & LUNGevity Foundation Funding: $75,000

Other than Principal Investigator

MSRG-18-216-01-CPHPS Nugent (PI) 4/1/2019-3/31/2023

Longitudinal Health-related Quality of Life among individuals Considering Treatment for Stage I Non-Small Cell Lung Cancer

The overall goal of this project is to better understand the pain management practices and preferences among survivors of head and neck cancer.

Role: Primary Mentor Source: American Cancer Society Funding: $728,860

FULL8140929 (Gogebakan) 10/06/20-04/06/22

Prioritization of Cancer Sites for Novel Screening Technologies

The goal of this project is to develop a population modeling framework for prioritizing cancer sites for novel early detection efforts applicable to three solid lethal cancer sites: lung, ovarian, and pancreatic cancers.

Role: Consultant Source: OHSU CEDAR Funding: $155,441

ATS pilot Sullivan (PI) 01/01/2020-12/31/2021

Improving Decision Making in All Stage Lung Cancer (I DESCide): A Conversation Tool Among Patients Making Treatment Decisions.

The purpose of this randomized control trial is to test the effectiveness of a decision aid among patients making lung cancer treatment-related decisions in clinical settings.

Role: Co-I Source: American Thoracic Society Funding: $98,279

1 IO1 CX001562 Harriff (PI) 01/01/18-12/31/21

Impact of COPD on Lung-Resident MAIT Cell Frequency, Function, and Recognition of Bacterial Infection

Establish how dysfunctional MAIT cell activation contributes to COPD pathology and define mechanisms driving impaired MAIT cell responses.

Role: Consultant Source: VA CSR&D Funding: $42,000/yr (local)

SWIFT Nugent & Vranas (Co-PIs) 10/10/20-09/30/21

Impact of the COVID-19 Pandemic on Patient-Clinician Relationships and the Well-Being of Frontline Clinicians: A Qualitative Study

The goal of this project is to understand the impact of the COVID-19 pandemic on the patient-clinician relationship and the well-being of frontline clinicians in the intensive care unit (ICU).

Role: Co-I Source: VA CIVIC Funding: $25,390

HSRD 18-075 Wiener (PI) 10/01/18 – 09/30/21

Achieving appropriate, safe, and patient-centered lung cancer screening

This proposal will lay the groundwork to inform future development, testing, and implementation of a personalized decision tool to optimize patient selection for lung cancer screening and facilitate shared decision-making between Veterans and VA clinicians at the point of care.

Role: Co-I Source: Department of Veterans Affairs HSRD Funding: Donated

1R01CA203193-01 Wisnivesky (PI) 04/01/16-03/31/21

Comparative Effectiveness of Limited Resection vs. SBRT

The goal of this study is to evaluate the association of common treatments for early stage lung cancer with short and medium-term health-related quality of life.

Role: Co-I Source: National Cancer Institute Funding: $560,000 (local)

COVID HSRD Hynes (PI) 07/01/2020-03/30/2021

COVID-19 Sequelae: Planning for What Comes Next

Rapid planning grant leveraging existing primary care cohort and data to develop criteria to identify COVID-19 cases and outcomes over the first year of recovery.

Role: Co-I Source: VA HSR&D Funding: $88,503

NRI 15-456 Reinke (PI) 10/01/17-09/30/20

Palliative Care Interventions for Outpatients Newly Diagnosed with Lung Cancer: Phase II

The purpose of this randomized control trial is to test the efficacy of delivering a nurse-led telephone-based intervention with the early provision of palliative care to improve patient-centered outcomes for Veterans with newly diagnosed lung cancer.

Role: Site PI Source: VA Nursing Research Funding: $58,436/yr (local)

NIH/NCI K07CA190706 Sullivan (PI) 9/21/15-8/31/20

The Impact of Specialist Palliative Care Utilization on Mortality and Other Outcomes Among Lung Cancer Patients within the Veterans Affairs Health Network

The goal of this project is to determine the association between palliative care utilization and patient outcomes and the quality of cancer care using the national Veterans Affairs (VA) healthcare system in a mixed-methods approach.

Role: Co-Mentor Source: National Institutes of Health Funding: $825,000

NIH-NHLBI 1K12HL133115 Newgard and Morris (PI) 07/01/2017-06/30/20

Hospital-level variation in ICU admitting patterns among patients presenting to the emergency department: a mixed-methods approach

The goal of this study is to examine the variability in ICU utilization across Veterans Affairs (VA) hospitals for patients who present to the ED with acute respiratory failure, and how this variability is associated with ICU bed supply; evaluate the association of ICU utilization for these patients with patient-centered outcomes; and qualitatively identify previously unmeasured, modifiable features of hospital healthcare delivery systems that are associated with variation in ICU admitting practice and outcomes.

Role: Primary Mentor Source: Oregon Health &Science University Funding: 0.75 FTE

HSRD IIR 15-091 Carlson (PI) 03/01/16 – 02/28/19

Use of a Prescription Drug Monitoring Program to Evaluate Concurrent VA and non-VA Opioid Prescriptions

This study will evaluate the epidemiology of opioid, benzodiazepine, and other controlled prescription medication dual use and all opioid-related adverse events among the entire population of Iraq and Afghanistan War Veterans in Oregon, while simultaneously assessing barriers to PDMP use among VA clinicians

Role: Co-I Source: Department of Veterans Affairs HSRD Funding: $824,573 (current)

1011220 Vranas (PI) 04/01/17-03/31/18

Association Between POLST Completion and Healthcare Resource Utilization

Examine differences in inpatient healthcare resource utilization among patients based on care preferences documented on Physicians Orders for Life-Sustaining Therapy (POLST), and study whether patients with POLST receive care that is consistent with their documented preferences.

Role: Co-I Source: Collins Medical Trust Funding: $23,700

1011011 Vranas (PI) 03/01/17-02/28/18

ICU Stratified Performers

Evaluate the association between admission to high-acuity ICUs versus low-acuity ICUs and the clinical outcomes of low-risk patients.

Role: Co-I Source: Medical Research Foundation Funding: $19,100

HSRD IIR 12-065-3 Zeliadt (PI) 01/01/14-12/31/16

A Novel Approach to Measuring Costs and Efficiency: Lung Nodules as a Case Study

The goal of this study is to measure the costs and resource utilization for patients with pulmonary nodules.

Role: Co-I Source: Department of Veterans Affairs HSR&D Funding: $990,002

PPO 14-130-2 Zeliadt (PI) 1/1/15-12/31/15

The goal is to demonstrate that a telephone-based intervention can feasibly be integrated into the routine care related to lung cancer screening, and that this intervention is well received by patients and helps connect patients with available tobacco cessation resources.

Role: Co-I Source: Department of Veterans Affairs Funding: $100,000

NIH/NCATS 5KL2TR000152-08 Sullivan (PI) 07/01/14-09/21/15

Role: Co-I Source: National Institutes of Health Funding: $300,000

SIP 13-068 Zeliadt (PI) 01/01/14-12/31/14

Low Dose CT Lung Cancer Screening: Informed Decision Making and Smoking Cessation

The goal of this study is to better understand how to discuss lung cancer screening as a possible smoking cessation intervention

Role: Co-I Source: CDC Funding: $222,604

RRP 12-533 Wiener (PI) 01/01/13-12/31/13

Progressing Towards Implementation of Lung Cancer Screening in the VHA

The goal of the project is to evaluate facilitators and barriers of lung cancer screening implementation.

Role: Co-I Source: Department of Veterans Affairs HSR&D Funding: $100,000

Publications/Creative work

Peer-reviewed Publications of Original Work/Research

Goitein L, Shanafelt TD, Wipf JE, Slatore CG, Back AL. The effects of work-hour limitations on resident well-being, patient care, and education in an internal medicine residency program. Arch Intern Med. 2005 Dec;165(22):2601-6. PMID:16344417.
Slatore CG, Littman AJ, Au DH, Satia JA, White E. Long-term use of supplemental multivitamins, vitamin c, vitamin e, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med. 2008 Mar;177(5):524-30. PMCID:PMC2258445.
Satia JA, Littman AJ, Slatore CG, Galanko JA, White E. Long-term use of β-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epi. 2009 April;169(7):815-28. PMCID:PMC2842198.
Slatore CG, Au DH, Hollingworth W. Cost Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer. J Thorac Oncol. 2009 April; 4(4):499-504. PMID:19204575
Slatore CG, Au DH, Littman AJ, Satia JA, White E. Association of Non-Steroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort Study. CEBP. 2009 April;18(4):1203-7. PMCID:PMC2692934.
Slatore CG, Bryson CL, Au DH. The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am J Med. 2009 May;122(5):472-8. PMID:19375557
Satia JA, Littman AJ, Slatore CG, Galanko JA, White E. Associations of specialty herbal supplements with lung and colorectal cancer risk in the VITamins And Lifestyle (VITAL) Study. CEBP 2009 May;18(5):1419-28. PMCID:PMC2814533.
Slatore CG, Chien JW, Au DH, Satia JA, White E. Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins And Lifestyle (VITAL) Study. J Clin Oncol. 2010 Mar 20;28(9):1540-6. PMCID:PMC2849773.
Slatore CG, Cecere LM, Reinke LF, Ganzini L, Udris EM, Moss BR, Bryson CL, Curtis JR, Au DH. Patient-Clinician Communication: Associations with Important Health Outcomes among Veterans with COPD. CHEST 2010 Sep;138(3):628-634. PMCID:PMC2940066.
Slatore CG, Au DH, Gould MK. An Official American Thoracic Society Systematic Review: Insurance Status and Disparities in Lung Cancer Practices Outcomes. Am J Respir Crit Care Med. 2010 Nov 1;182(9):1195-1205. PMID: 21041563.
Reinke LF, Slatore CG, Udris EM, Moss BR, Johnson EA, Au DH. The association of depression and preferences for life-sustaining treatments in Veterans with Chronic Obstructive Pulmonary Disease. J Pain Symptom Manage. 2011 Feb;41(2):402-11. PMID:21145201.
Slatore CG, Gould MK, Au DH, Deffebach ME, White E. Lung Cancer Stage at Diagnosis: Individual Associations in the Prospective VITamins And Lifestyle (VITAL) Study. BMC Cancer. 2011 Jun 7;11:228. PMCID:PMC3129325.
Reinke LF, Slatore CG, Uman J, Udris E, Moss BR, Engelberg RA, Au DH. Patient-clinician communication about end-of-life care topics: Is anyone talking to patients with COPD? J Palliat Med. 2011 Aug;14(8):923-8. PMID:21631367
Cecere LM, Littman AJ, Slatore CG, Udris EM, Bryson CL, Au DH. Obesity and COPD: Associated Symptoms, Health-related Quality of Life, and Medication Use. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2011 Aug;8:4, 275-84. PMCID:PMC3169653.
Brasky TM, Lampe JW, Slatore CG, White E. Use of Glucosamine and Chondroitin and Lung Cancer Risk: Results from the VITamins And Lifestyle (VITAL) Cohort. Cancer Causes and Control. 2011 Sep;22(9):1333-42. PMCID:PMC3175750.
Zeliadt SB, Sekaran NK, Hu E, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC. Comparison of Demographic Characteristics, Surgical Resection Patterns and Survival Outcomes for Veterans and Non-Veterans with Non-Small Cell Lung Cancer in the Pacific Northwest. J Thorac Oncol. 2011 Oct;6(10):1726-1732. PMID: 21857253.
Slatore CG, Goy ER, O’Hearn DJ, Boudreau EA, O’Malley JP, Peters D, Ganzini L. Sleep Quality and its Association with Delirium among Veterans enrolled in Hospice. Am J Geriatr Psychiatry. 2012 April;20(4):317-326. PMCID:PMC3440244
Slatore CG, Cecere LM, LeTourneau J, O’Neil ME, Duckart JP, Soylemez-Wiener R, Farjah F, Cooke CR. Intensive Care Unit Outcomes among Patients with Lung Cancer in the SEER-Medicare Registry. J Clin Oncol. 2012 May 10;30(14):1686-91. PMCID:PMC3383114.
Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. Adherence to Long-Acting Beta Agonists and Inhaled Corticosteroids in COPD. COPD: J of COPD. 2012 Jun;9(3):251-8. PMID:22497533.
Brasky TM, Baik CS, Slatore CG, Potter JD, White E. Non-steroidal Anti-inflammatory Drugs and Small Cell Lung Cancer Risk in the VITAL Study. Lung Cancer. 2012 Aug;77(2):260-264. PMCID:PMC3552491.
Brasky TM, Baik CS, Slatore CG, Alvarado M, White E. Prediagnostic Nonsteroidal Anti-Inflammatory Drug Use and Lung Cancer Survival in the VITAL Study. J Thorac Oncol. 2012 Oct;7(10):1503-1512; PMCI:PMC3445269.
Slatore CG, Hansen L, Ganzini L, Press N, Osborne ML, Chesnutt MS, Mularski RA. Communication by Nurses in the Intensive Care Unit: Qualitative Analysis of Domains of Patient-Centered Care. AJCC. 2012 Nov;21(6):410-418. PMID: 23117904.
Slatore CG, Press N, Au DH, Curtis JR, Wiener RS, Ganzini L. What the Heck is a “Nodule”? A Qualitative Study of Veterans with Pulmonary Nodules. Ann Am Thorac Soc. 2013 Aug;10(4):330-5. PMID:23952851.
Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Slatore CG. Screening for Lung Cancer with Low-dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2013 Sep 17;159(6):411-420. PMID:23897166
Slatore CG, Harber P, Haggerty MC. An Official American Thoracic Society Systematic Review: Influence of Psychosocial Characteristics on Workplace Disability among Workers with Respiratory Impairment. AJRCCM. 2013 Nov 1;188(9):1147-1160. PMID:24180441.
Sullivan DR, Ganzini L, Duckart JP, Lopez-Chavez A, Deffebach ME, Thielke SM, Slatore CG. Treatment Receipt and Outcomes among Lung Cancer Patients with Depression. Clin Oncol (R Coll Radiol). 2014 Jan;26(1):25-31. PMID:24080122.
Zeliadt WB, Loggers ET, Slatore CG, Au DH, Kessler LG, Backhus LM. Preoperative PET and the Reduction of Unnecessary Surgery Among Newly Diagnosed Lung Cancer Patients in a Community Setting. J Nucl Med. 2014 Mar;55(3):379-85. PMID:24449594.
Slatore CG, Baumann C, Pappas M, Humphrey LL. Smoking behaviors among patients receiving computed tomography for lung cancer screening: a systematic review. Ann Am Thorac Soc. 2014 May;11(4):619-27. PMID:24701999.
Wiener RS, Gould MK, Slatore CG, Fincke BG, Schwartz LM, Woloshin S. Resource Use and Guideline Concordance in Evaluation of Pulmonary Nodules for Cancer: Too much and too little care. JAMA IM. 2014 Jun;174(6):871-80 PMID:24710850
Zhang Z, Duckart J, Slatore CG, Fu Y, Petrik A, Thorpe M, Cohen DM. Individuality of the plasma sodium concentration. Am J Physiol Renal Physiol. 2014 Jun 15;306(12)F1534-43. PMID:24717732.Slatore CG, Sullivan DR, Pappas M, Humphrey L. Patient-centered outcomes among lung cancer screening recipients with computed tomography: A Systematic Review. J Thorac Oncol. 2014 Jul;9(7):927-34. PMID:24922011.
Clark N, Fan V, Slatore CG, Locke E, Whitson H, Nici L, Thielke SM. Dyspnea and pain are strongly associated among Medicare Managed Care Recipients. Ann Am Thorac Soc. 2014 Jul;11(6):890-7. PMID:24960243
Slatore CG, Feemster LC, Au DH, Engelberg RA, Curtis JR, Uman, J, Reinke LF. Which patient and clinician characteristics are associated with high quality communication among Veterans with COPD?. J Health Communication. 2014 Aug;19(8):907-21. PMID:24558957.
Cooke CR, Feemster LC, Wiener RS, Slatore CG. Aggressiveness of intensive care use among patients with lung cancer in the SEER-Medicare registry. CHEST. 2014 Oct 1;146(4):916-23. PMID:25117058
Sullivan DR, Ganzini L, Lopez-Chavez A, Slatore CG. Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancer. Psychooncology. 2014 Nov;23(11):1318-22. PMID:24771684.
Smith MEB, Chiovaro J, O’Neil M, Kansagara D, Quinones A, Freeman M, Motu’apuaka M, Slatore CG. Early Warning Scoring Systems: A Systematic Review. Ann Am Thorac Soc. 2014 Nov;11(9):1466-75. PMID:25296111.
Slatore CG, Golden SE, Ganzini L, Wiener RS, Au DH. Distress and patient-centered communication among Veterans with incidental (not screen-detected) pulmonary nodules: a cohort study. Ann Am Thorac Soc. 2015 Feb;12(2):184-92. PMID:25521482
Slatore CG, Au DH, Press N, Wiener RS, Golden SE, Ganzini L. Decision Making among Veterans with Incidental Pulmonary Nodules: A Qualitative Analysis. Respir Med. 2015 Apr;109(4):532-539. PMID:25660437
Sullivan DR, Golden SE, Ganzini L, Hansen L, Slatore CG, “I still don’t know diddly”: A longitudinal qualitative study of patients’ knowledge and distress while undergoing evaluation of incidental pulmonary nodules. NPJ Prim Care Resp Med. 2015 Apr 16;25:15028. PMID:26028564
Iaccarino JM, Clark JA, Bolton R, Kinsinger L, Kelly M, Slatore CG, Au DH, Wiener RS. A national survey of VA pulmonologists’ views on low-dose CT screening for lung cancer: screening propensity, guideline concordance, and implications for implementation. Ann Am Thorac Soc. 2015 Nov;12(11):1667-75. PMID:26368003
Thielke SM, Slatore CG, Banks WA. Association between Alzheimer dementia mortality rate and altitude in California counties. JAMA Psychiatry. 2015 Dec 1;72(12):1253-4. PMID:26502029.
Wiener RS, Slatore CG, Gillespie C, Clark JA. Pulmonologists’ reported use of guidelines and shared decision-making in evaluation of pulmonary nodules: a qualitative study. CHEST. 2015 Dec 1;148(6):1415-21. PMID:25789979
Golden SE, Wiener RS, Sullivan DR, Ganzini L, Slatore CG. Primary care providers and a system problem: a qualitative study of clinicians caring for patients with incidental pulmonary nodules. CHEST. 2015 Dec 1;148(6):1422-9. PMID:25790082.
Freiman MR, Clark JA, Slatore CG, Gould MK, Woloshin S, Schwartz LM, Wiener RS. Patients’ knowledge, beliefs, and distress associated with detection and evaluation of incidental pulmonary nodules: results from a multi-center survey. J Thorac Oncol. 2016 May;11(5):700-8. PMID:26961390.
Moseson EM, Wiener RS, Golden SE, Au DH, Gorman JD, Laing AD, Deffebach ME, Slatore CG. Patient and clinician characteristics associated with adherence: A cohort study of Veterans with incidental pulmonary nodules. Ann Am Thorac Soc. 2016 May;13(5):651-9. PMID:27144794
Simmons J, Gould MK, Slatore CG, Wiener RS. Systems-Level Resources for Pulmonary Nodule Evaluation in the United States: A National Survey. AJRCCM. 2016 May 1;193(9):1063-5. PMID:27128706.
Isenberg J, Slatore CG, Quinones A, Thielke S. Trends in Cigarette Smoking Among Medicare Managed Care Recipients, 2005-2012. Addictive Behaviors. 2016 Jul;58:155-60. PMID:26946446.
Golden SE, Thomas CR, Deffebach ME, Sukumar, MS, Schipper PH, Tieu BH, Kee AY, Tsen AC, Slatore CG. “Even if I don’t remember, I feel better”: A qualitative study of early stage non-small cell lung cancer patients undergoing stereotactic body radiotherapy or surgery. Ann Am Thorac Soc. 2016 Aug;13(8):1361-9. PMID:27182889.
Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale DK, Lyons KS, Slatore CG. Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer. 2016 Oct;100:102-09. PMID:27597288.
Tukey MH, Clark JA, Bolton R, Kinsinger L, Kelley M, Slatore CG, Au DH, Wiener RS. Readiness for Implementation of CT Lung Cancer Screening in the Veterans Health Administration: A National Survey. Ann Am Thorac Soc. 2016 Oct;13(10)1794-1801. PMID:27409524.
Slatore CG, Wiener RS, Golden SE, Au DH, Ganzini L. Longitudinal Assessment of Distress Among Veterans with Incidental Pulmonary Nodules. Ann Am Thorac Soc. 2016 Nov;13(11):1983-1991. PMID:27599153
Crothers K, Kross E, Reisch LM, Shahrir S, Slatore CG, Zeliadt SB, Triplette M, Meza R, Elmore JG. Patients’ attitudes regarding lung cancer screening and decision aids: a survey and focus group study. Ann Am Thorac Soc. 2016 Nov;13(11):1992-2001. PMID:27652509.
Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale DK, Slatore CG. Longitudinal Changes in Depression Symptoms and Survival among Patients with Lung Cancer: A National Cohort Assessment. J Clin Oncol. 2016 Nov 20;34(33)3984-3991. PMID:27996350
Thielke S, Slatore CG, Banks WA. Quantifying altitude of human habitation in studies of human health using geographical name server data. Geospat Health. 2016 Nov; 21;11(3):463. PMID:27903068
Kinsinger LS, Anderson C, Kim J, Larsa M, Chan SH, King HA, Rice KL, Slatore CG, Tanner NT, Pittman K, Monte RJ, McNeil RB, Grubber JM, Kelley MJ, Provenzale D, Datta SK, Sperber NS, Barnes KL, Abbott DH, Sims KJ, Whitley RL, Wu RR, Jackson GL. Implementation of lung cancer screening: The experience of the Veterans Health Administration. JAMA Int Med. 2017 Mar 1;177(3):399-406. PMID:28135352
Golden SE, Thomas CR, Moghanaki D, Slatore CG. Dumping the information bucket: a qualitative study of clinicians caring for patients with early stage non-small cell lung cancer. Patient Educ Couns. 2017 May;100(5): 861-870 PMID:28034611
Iaccarino JM, Simmons J, Gould MK, Slatore CG, Woloshin S, Schwartz LM, Wiener RS. Clinical equipoise and shared decision making in pulmonary nodule management – a survey of American Thoracic Society clinicians. Ann Am Thorac Society. 2017 Jun;14(6):968-975. PMID:28278389.
Gesthalter Y, Koppelman E, Bolton R, Slatore CG, Yoon S, Cain H, Tanner N, Au DH, Clark J, Wiener RS. Evaluations of implementation at early-adopting lung cancer screening programs: lessons learned. CHEST. 2017 Jul;152(1):70-80. PMID:28223153.
Novosad SA, Henkle E, Schafer S, Hedberg K, Ku J, Siegel SAR, Dongseok C, Slatore CG, Winthrop KL. Mortality after Respiratory Isolation of Nontuberculous Mycobacteria: A Comparison of Patients Who Did and Did Not Meet Disease Criteria. Ann Am Thorac Society. 2017 Jul;14(7):1112-1119. PMID:28387532
Vranas KC, Jopling JK, Sweeney TE, Ramsey MC, Milstein AS, Slatore CG, Escobar GJ, Liu VX. Identifying distinct subgroups of ICU patients: A machine learning approach. Crit Care Med. 2017 Oct;45(10):1607-1615. PMID:28640021.
Miranda L, Datta S, Melzer A, Wiener RS, Davis J, Tong B, Golden S, Slatore CG. Rationale and Design of the Lung Cancer Screening Implementation. Evaluation of Patient-Centered Care Study. Ann Am Thoracic Society. 2017 Oct;14(10):1581-1590. PMID:28640670.
Sullivan DR, Golden SE, Ganzini L, Wiener RS, Eden, K, Slatore CG. Association of decision-making with patients’ perceptions of care and knowledge during longitudinal pulmonary nodule surveillance. Ann Am Thorac Society. 2017 Nov;14(11):1690-1696. PMID:28489453.
Golden SE, Thomas CR, Deffebach ME, Sukumar MS, Schipper PH, Tieu BH, Kee AY, Tsen AC, Slatore CG. “It wasn’t as bad as I thought it would be”: a qualitative study of early stage non-small cell lung cancer patients after treatment. BMC Res Notes. 2017 Nov 29;10(1):642. PMID:29187237.
Triplette M, Kross E, Mann B, Elmore J, Slatore CG, Shahrir S, Romine P, Frederick P, Crothers K. An assessment of primary care and pulmonary provider perspectives on lung cancer screening." Ann Am Thorac Society. 2018 Jan;15(1):69-75. PMID:28933940.
Sullivan DR, Ganzini L, Lapidus JA, Hansen L, Carney PA, Osborne ML, Fromme EK, Izumi S, Slatore CG. Improvements in hospice utilization among patients with advanced stage lung cancer in an integrated health care system. Cancer. 2018 Jan 15;124(2):426-433. PMID:29023648.
Lammers A, Mitin T, Moghanaki D, Thomas CR, Timmerman R, Golden SE, Thakurta S, Dziadziuszko R, Slatore CG. Brief Report: lung cancer specialists’ opinions on treatment for stage I non-small cell lung cancer: a multidisciplinary survey. (Research Letter). Adv Rad Onc. 2018 Jan 31;3(2):125-129. PMID:29904736
Caverly TJ, Fagerlin A, Wiener RS, Slatore CG, Tanner NT, Yun S, Hayward R. Comparison of observed harms and expected mortality benefit for persons in Veterans Affairs lung cancer screening demonstration project. (Research Letter). JAMA Int Med. 2018 Mar 1;178(3):426-428. PMID:29356812.
Vranas K, Jopling J, Scott J, Badawi O, Harhay M, Slatore C, Ramsey M, Breslow M, Milstein A, Prasad Kerlin M. The association of intensive care unit acuity with outcomes of patients at low risk of dying. Crit Care Med. 2018 Mar;46(3):347-353. PMID:29474319.
Slatore CG, Wiener RS. Pulmonary nodules: a small problem for many, severe distress for some, and how to communicate about it. CHEST. (Research Review (peer-reviewed). 2018 Apr;153(4):1004-1015. PMID:29066390
Nugent SM, Golden SE, Thomas CR, Deffebach ME, Sukumar MS, Schipper PH, Tieu BH, Moghanaki D, Wisnivesky J, Slatore CG. Patient-clinician communication among patients with stage I lung cancer. Supp Care Can. 2018 May;26(5):1625-1633. PMID:29209835.
Slatore CG, Falvo MJ, Nugent S, Carlson K. Afghanistan & Iraq War Veterans: Mental health diagnoses are associated with respiratory disease diagnoses. Mil Med. 2018 May 1;183(5-6):e248-e257. PMID:29420832.
Wiener RS, Koppelman E, Bolton R, Lasser K, Borrelli B, Au DH, Slatore CG, Clark JA, Kathuria H. Patient and clinician perspectives on shared decision-making in early-adopting lung cancer screening programs: a qualitative study. J Gen Intern Med. 2018 July;33(7):1035-42. PMID:29468601.
Heffner JL, Krebs P, Johnson H, Greene PA, Klein DE, Feemster LC, Slatore CG, Au DH, Zeliadt SB. Smokers’ inaccurate beliefs about the benefits of lung cancer screening. (Research Letter). Ann Am Thorac Society. 2018 Sep;15(9):1110-3. PMID:29877728.
Zeliadt SB, Greene PA, Krebs P, Klein D, Swanson LD, Todd K, Feemster L, Au DH, Reinke LF, Slatore CG, Heffner J. A proactive telephone-delivered motivational risk communication intervention for smokers participating in lung cancer screening: a pilot feasibility trial. J Smoking Cessation. 2018 Sep;13(3)137-144. https://doi.org/10.1017/jsc.2017.16. (No PMID)
Golden SE, Thakurta S, Slatore CG, Woo H, Sullivan DR. Military factors associated with smoking in Veterans. (Research Letter). Mil Med. 2018 Nov 1;183(11-12):e402-408. PMID:29788494.
Sullivan DR. Forsberg CW, Golden SE, Ganzini L, Dobscha SK, Slatore CG. Incidence of suicide and associations with palliative care among patients with advanced lung cancer. (Research Letter). Ann Am Thorac Society. 2018 Nov;15(11)1357-59. PMID:30048151.
Lammers A, Slatore CG, Fromme EK, Vranas K, Sullivan DR. Association of early palliative care with chemotherapy intensity in patients with advanced stage lung cancer: a national cohort study. J Thorac Onc. 2019 Feb;14(2)176-183. PMID:30336324.
Iaccarino JM, Duran C, Slatore CG, Wiener RS, Kathuria H. Combining smoking cessation interventions with LDCT lung cancer screening: a systematic review. Prev Med. 2019 Apr;121:24-32. PMID:30753860
Melzer AC, Golden SE, Wiener RS, Iaccarino JM, Slatore CG. A brief report of smoking behaviors in patients with incidental pulmonary nodules: associations with communication and risk perception. Tobacco Use Insights. 2019 Apr 15;12:1179173X19839059. PMID:31019369
Sullivan DR, Eden KB, Dieckmann NF, Golden SE, Vranas KC, Nugent SM, Slatore, CG. Understanding patients’ values and preferences regarding early stage lung cancer treatment decision making. Lung Ca. 2019 May;131:47-57. PMID:31027697
Nugent SM, Slatore CG, Ganzini L, Golden SE, Zive D, Vranas KC, Sullivan DR. POLST registration and associated outcomes among veterans with advanced stage lung cancer. Am J Hosp Palliat Care. 2019 Jul;36(7):564-570. PMID:30700127
Sullivan DR, Lapidus JA, Golden SE, Carney P, Ganzini L, Fromme E, Hansen L, Chan B, Marino M, Vranas KC, Slatore CG. Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration. JAMA Onc. 2019, Sep 19. doi: 10.1001/jamaoncol.2019.3105. [Epub ahead of print]. PMID:31536133.
Yong PC, Sigel KM, de Torres JP, Mhango G, Kale M, Kong CY, Zulueta J, Wilson D, Whittaker Brown SA, Slatore C, Wisnivesky JP. The effect of radiographic emphysema in assessing lung cancer risk. Thorax. 2019 Sep;74(9):858-864. PMID:30723183.
Golden SE, Hooker ER, Shull S, Howard M, Crothers K, Thompson RJ, Slatore CG. Validity of VHA structured data to determine accurate smoking status. Health Informatics Journal. 2019 Sep;37(5):579-588. PMID:31679173.
Vranas KC, Lin AL, Zive D, Tolle SW, Halpern SD, Slatore CG, Newgard C, Lee RY, Kross EK, Sullivan DR. The Association of Physician Orders for Life-Sustaining Treatment With Intensity of Treatment Among Patients Presenting to the Emergency Department. Ann Emerg Med. 2020 Feb;75(2):171-180. PMID:31248675
Melzer AC, Golden SE, Ono SS, Datta S, Crothers K, Slatore CG. “What exactly is Shared Decision-Making?”: A Qualitative Study of Shared Decision-Making in Lung Cancer Screening. J Gen Intern Med. 2020 Feb;35(2):546-553. PMID:31745852.
Kathuria H, Koppelman E, Borreli B, Slatore CG, Clark JA, Lasser KE, Wiener RS. Patient-physician discussions on lung cancer screening: a missed teachable moment to promote smoking cessation. Nicotine Tob Res. 2020 Mar 16;22(3):431-439 . PMID:30476209.
Vranas KC, Ouyang D, Lin AL, Slatore CG, Sullivan DR, Kerlin MP, Liu KD, Baron RM, Calfee CS, Ware LB, Halpern S, Matthay MA, Herridge M, Mehta S, Rogers AJ. Gender differences in authorship of critical care literature. Am J Respir Crit Care Med. 2020 Apr 1;201(7)L840-847. PMID:31968182
Vranas KC, Scott JY, Badawi O, Harhay MO, Slatore CG, Sullivan DR, Kerlin MP. The Association of ICU Acuity With Adherence to ICU Evidence-Based Processes of Care. Chest. 2020 Aug;158(2):579-587. PMID: 32229228
Nugent SM, Golden SE, Hooker ER, Sullivan DR, Thomas CR, Deffebach ME, Sukumar MS, Schipper PH, Tieu BH, Moghanaki D, Wisnivesky J, Samson P, Robinson C, Slatore CG. Longitudinal health-related quality of life among individuals considering treatment for stage I non-small cell lung cancer. Ann Am Thorac Soc. 2020 Aug;17(8):988-997. PMID: 32433897
Golden SE, Ono SS, Thakurta S, Wiener RS, Iaccarino JM, Melzer AC, Datta S, Slatore CG. “I’m putting my trust in their hands”: A qualitative study of patients’ views on clinician initial communication about lung cancer screening. Chest. 2020 Sep;158(3):1260-1267. PMID: 32278782.
Golden SE, Ono SS, Melzer A, Davis J, Zeliadt SB, Heffner JL, Kathuria H, Garcia-Alexander G, Slatore CG, “I already know that smoking ain’t good for me”: Patient and clinician perspectives on lung cancer screening decision-making discussions as a teachable moment. Chest. 2020 Sep;158(3):1250-1259. PMID: 32304776
Wiener RS, Clark J, Koppelman E, Bolton R, Fix G, Slatore CG, Kathuria, H. Patient versus clinician perspectives on communication about results of lung cancer screening: a qualitative study. Chest. 2020 Sep;158(3):1240-1249. PMID: 32387521
Iaccarino JM, Steiling K, Slatore CG, Drainoni ML, Wiener RS. Patient characteristics associated with adherence to pulmonary nodule guidelines. Resp Med. 2020 Sep; 171:106075. PMID: 32658836.
Tanner, NT, Slatore CG, Brasher B, Wojciechowki B, Ward RC, Sivestri G. Screening adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 Oct;158(4):1742-1752t. PMID: 32439505
Melzer A, Golden SE, Ono S, Datta S, Triplette M, Slatore CG. “We just never have enough time” Clinician views of lung cancer screening process and implementation. Ann Am Thorac Society. 2020 Oct; 17(10):1264-1272. PMID: 32497437
Lewis JA, Samuels LR, Denton J, Edwards GC, Matheny ME, Maiga A, Slatore CG, Grogan E, Kim J, Sherrier RH, Dittus RS, Massion PR, Keohane L, Nikpay S, Roumie CL. National lung cancer screening utilization trends in the Veterans Health Administration. JNCICS. 2020 Jun 13;4(5): eCollection 2020 Oct. PMID: 33490864.
Vranas KC, Lapidus JA, Ganzini L, Slatore CG, Sullivan DR. Association of Palliative Care Use and Setting With Health-care Utilization and Quality of Care at the End of Life Among Patients With Advanced Lung Cancer. Chest. 2020 Dec;158(6):2667-2674. PMID: 32589949
Spalluto LB, Lewis JA, Stolldorf D, Yeh VM, Callaway-Lane C, Wiener RS, Slatore CG, Yankelevitz DF, Henschke CI, Vogus TJ, Massion PP, Moghanaki D, Roumie CL. Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center. J Am Coll Radiol. 2021 Jun;18(6):809-819. Erratum in: J Am Coll Radiol. 2021 Sep;18(9):1371. PMID: 33421372
Núñez ER, Caverly TJ, Zhang S, Glickman ME, Qian SX, Boudreau JH, Slatore CG, Miller DR, Wiener RS. Adherence to Follow-up Testing Recommendations in US Veterans Screened for Lung Cancer, 2015-2019. JAMA Netw Open. 2021 Jul 1;4(7):e2116233. PMID: 34236409
Vranas KC, Golden SE, Mathews KS, Schutz A, Valley TS, Duggal A, Seitz KP, Chang SY, Nugent S, Slatore CG, Sullivan DR, Hough CL. The Influence of the COVID-19 Pandemic on ICU Organization, Care Processes, and Frontline Clinician Experiences: A Qualitative Study. Chest. 2021 Nov;160(5):1714-1728. PMID: 34062115; PMCID: PMC8164514.
Nugent SM, Morasco BJ, Handley R, Clayburgh D, Hooker ER, Ganzini L, Knight SJ, Chen JI, Sullivan DR, Slatore CG. Risk of Suicidal Self-directed Violence Among US Veteran Survivors of Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2021 Nov 1;147(11):981-989. Erratum in: JAMA Otolaryngol Head Neck Surg. 2022 Feb 1;148(2):200. PMID: 34617963
Slatore CG, Golden SE, Thomas T, Bumatay S, Shannon J, Davis M. "It's Really Like Any Other Study": Rural Radiology Facilities Performing Low-Dose Computed Tomography for Lung Cancer Screening. Ann Am Thorac Soc. 2021 Dec;18(12):2058-2066. PMID: 34129451
Vranas KC, Plinke W, Bourne D, Kansagara D, Lee RY, Kross EK, Slatore CG, Sullivan DR. The influence of POLST on treatment intensity at the end of life: A systematic review. J Am Geriatr Soc. 2021 Dec;69(12):3661-3674. PMID: 34549418; PMCID: PMC8648994.
Slatore CG, Golden SE, Thomas T, Patzel M, Bumatay S, Shannon J, Davis M. Beliefs and Practices of Primary Care Providers Regarding Performing Low-Dose CT Studies for Lung Cancer Screening. Chest. 2022 Mar;161(3):853-859. PMID: 34480957
Khan AM, McGrath LB, Ramsey K, Agarwal A, Slatore CG, Broberg CS. Distance to Care, Rural Dwelling Status, and Patterns of Care Utilization in Adult Congenital Heart Disease. Pediatr Cardiol. 2022 Mar;43(3):532-540. PMID: 34705069
Chen JI, Hickok A, O'Neill AC, Niederhausen M, Laliberte AZ, Govier DJ, Edwards ST, Gordon HS, Slatore CG, Weaver FM, Young R, Hynes DM. Psychiatric disorders newly diagnosed among veterans subsequent to hospitalization for COVID-19. Psychiatry Res. 2022 Jun;312:114570. PMID: 35487047.
Braithwaite D, Karanth SD, Slatore CG, Zhang D, Bian J, Meza R, Jeon J, Tammemagi MC, Schabath MB, Wheeler M, Guo Y, Hochhegger B, Kaye FJ, Silvestri, Gould MK. Study protocol: personalized lung cancer screening (PLuS) study to assess the importance of co-existing chronic conditions to clinical practice and policy. BMJ Open. 2022 Jun 22;12(6):e064142. PMID: 35732383
Hedstrom GH, Hooker ER, Howard M, Shull S, Golden SE, Deffebach ME, Gorman JD, Murphy K, Fabbrini A, Melzer AC, Slatore CG. The Chain of Adherence for Incidentally-detected Pulmonary Nodules after an Initial Radiologic Imaging Study: A Multi-system Observational Study. Ann Am Thorac Soc. 2022 Aug;19(8):1379-1389. PMID: 35167780
Vranas KC, Golden SE, Nugent S, Valley TS, Schutz A, Duggal A, Seitz KP, Chang SY, Slatore CG, Sullivan DR, Hough CL, Mathews KS. The Influence of the COVID-19 Pandemic on Intensivists' Well-Being: A Qualitative Study. Chest. 2022 May 11:S0012-3692(22)00898-4. PMID: 35568205.
Vranas KC, Hooker ER, Golden SE, Nugent S, Slatore CG. Association of communication quality with patient-centered outcomes among patients with incidental pulmonary nodules (Research Letter). Chest. 2023 Mar 11:S0012-3692(23)00332-X. PMID: 36907374.
Nunez ER, Caverly TJ, Sangian Z, Glickman ME, Qian SX, Boudreau JH, Miller DR, Slatore CG, Wiener RS. Factors associated with declining lung cancer screening after shared decision making in a national cohort of Veterans. JAMA Netw Open. 2022 Aug 1;5(8):e2227126. PMID: 35972738.
Lewis JA, Samuels LR, Denton J, Matheny ME, Maiga A, Slatore CG, Grogan E, Kim J, Sherrier RH, Dittus RS, Massion PP, Keohane L, Roumie CL, Nikpay S. The Association of Healthcare System Resources with Lung Cancer Screening Implementation: A Cohort Study. Chest. 2022 Sep;162(3):701-711. PMID: 35413280
Nugent SM, Golden SE, Sullivan DR, Thomas DR, Wisnivesky J, Saha S, Slatore CG. Patient-clinician communication and longitudinal patient-centered outcomes among patients with suspected stage I non-small cell lung cancer: a prospective cohort study. Medical Oncology. Med Oncol. 2022 Sep 29;39(12):203. PMID: 36175802.
Unger S, Golden SE, Melzer A, Tanner N, Deepak J, Delorit M, Scott JY, Slatore CG. Study design for a proactive teachable moment smoking cessation intervention among patients with pulmonary nodules. Contemp Clin Trials. 2022 Oct;121:106908. PMID: 36087843.
Rozema EJ, Creekmur B, Musigdilok VV, Steltz J, Gould MK, Slatore CG. Patient responses to passive enrollment into a large, pragmatic clinical trial: A qualitative content analysis. Contemp Clin Trials. 2022 Oct;121:106925. PMID: 36108887.
Reinke LF, Sullivan DR, Slatore CG, Dransfield MT, Ruedebusch S, Smith P, Rise PJ, Tartaglione EV, Vig EK, Au DH. A Randomized Trial of a Nurse-Led Palliative Care Intervention for Patients with Newly Diagnosed Lung Cancer. J Palliat Med. 2022 Nov;25(11):1668-1676.PMID: 35649214.
Wang Q, Stone K, Kern JA, Slatore CG, Swanson S, Blackstock W Jr, Khan RS, Smith CB, Veluswamy RR, Chidel M, Wisnivesky JP. Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer. Ann Am Thorac Soc. 2022 Dec;19(12):2053-2061.PMID: 35816617.
Golden SE, Schweiger L, Melzer AC, Ono SS, Datta S, Davis JM, Slatore CG. "It's a decision I have to make": Patient perspectives on smoking and cessation after lung cancer screening decisions. Prev Med Rep. 2022 Oct 5;30:102014. PMID: 36237837.
Golden SE, Disher N, Dieckmann N, Eden KB, Matlock D, Vranas KC, Slatore CG, Sullivan DR. Show me the roads and give me a road map: Development of a patient conversation tool to improve lung cancer treatment decision-making. PEC Innovation. PEC Innov. 2022 Oct 21;1:100094. PMID: 37213736
Schweiger L, Vranas KD, Furuno JP, Hansen L, Slatore CG, Sullivan DR. Association of patient-centered elements of care and palliative care in patients with lung cancer. Am J Hosp Palliat Care. 2023 Jan;40(1):18-26. PMID: 36191296.
Sullivan DR. Vranas KC, Golden SE, Delorit M, Slatore CG, Ganzini L, Hansen L. Relationships among Clinicians are Crucial to Successful Palliative Care Integration: A Qualitative Study in Lung Cancer. Future Oncology. 2023 Mar 28. PMID: 36974605.
Gogebakan KC, Lange J, Slatore CG, Etzioni R. Modeling the impact of novel systemic treatments on lung cancer screening benefits. Cancer. 2023 Jan 15;129(2):226-234. PMID: 36320180.
Gundle K, Hooker ER, Golden SE, Shull S, Crothers K, Melzer AC Slatore CG. Use of Veterans Health Administration structured data to identify patients eligible for lung cancer screening. (Research Letter). Mil Med. 2023 Jan 31:USAD017. PMID: 36722178.
Gershengorn HB, Vranas KC, Ouyang D, Cheng S, Rogers AJ, Schweiger L, Cooke CR, Slatore CG. Influence of the COVID-19 Pandemic on Author Gender and Manuscript Acceptance Rates among Pulmonary and Critical Care Journals. Ann Am Thorac Soc. 2023 Feb;20(2):215-225. PMID: 35588358.
Nugent SM, Golden SE, Chapa J, Tupeker A, Slatore CG, Vranas KC. “You’re socially distant and trying not to be emotionally distant.” Physicians’ perspectives of communication and therapeutic relationships in the Intensive Care Unit during the COVID-19 pandemic: A qualitative study. Crit Care Explor. 2023 Feb 16;5(2):e0854. PMID: 36817963.
Lafferty M, Govier D, Golden SE, Disher NG, Hynes DM, Slatore CG. VA-Delivered or VA-Purchased Care: important factors for Veterans navigating care decisions. J Gen Intern Med. 2023 May;38(7):1647-1654. PMID: 36922468
Sullivan DR, Wisnivesky JP, Nugent SM, Stone K, Farris MK, Kern JA, Swanson S, Smith CB, Rosenzweig K, Slatore CG. Decision regret among patients with early stage lung cancer undergoing radiation. Clin Onc. Clin Oncol (R Coll Radiol). 2023 Jun;35(6):e352-e361. PMID: 37031075
Rustagi AS, Byers AL, Brown JK, Purcell N, Slatore CG, Keyhani S. Lung cancer screening among U.S. military veterans by health status and race and ethnicity, 2017-2020. AJPM Focus. 2023 Feb 9;2(2):100084. PMID: 37790642
Nugent SM, Slatore CG, Winchell K, Handley R, Clayburgh D, Chandra R, Hooker ER, Knight SJ, Morasco BJ. Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer. Head Neck. 2023 Aug;45(8):2058-2067. PMID: 37366072
Kearney L, Butler C, Nunez E, Qian S, Slatore CG, Spalluto L, Wiener RS. Highly variable reporting of incidental findings in a national cohort of US Veterans screened for lung cancer. Clin Imaging. 2023 Aug:100:21-23. PMID: 37146522
Nunez ER, Slatore CG, Tanner NT, Melzer AC, Crothers K, Lewis JA, Fabbrini A, Brown JK, Wiener RS. National survey of lung cancer screening program models and practices in Veterans Health Administration facilities. Am J Prev Med. 2023 Nov;65(5):901-905. PMID: 37169315
Lewis JA, Samuels L, Weems J, Park D, Winter R, Callaway-Lane C, Lindsell C, Slatore CG, Wiener R, Dittus R, Yankelevitz D, Henschke CI, Kripalani S, Moghanaki D, Matheny M, Vogus T, Roumie C, Spalluto L. The association of organizational readiness with lung cancer screening utilization. Am J Prev Med. 2023 Nov;65(5):844-853. PMID: 37224985
Hooker ER, Chapa J, Vranas KC, Niederhausen M, Goodlin SJ, Slatore CG, Sullivan DR. The intersection of palliative care and hospice use among patients with advanced lung cancer. J. Pall Med. 2023 Jun 1. PMID: 37262128.
Golden SE, Lafferty M, Tyzik A, Govier D, Barton J, Teo A, Edwards S, Ono S, Hynes D, Slatore CG. A qualitative study of VA stakeholders’ experiences discussing community care with Veterans. Sage Open. 2023 Oct;13(4).
Gould MK, Creekmur B, Qi L, Golden SE, Kaplan CP, Walter E, Mularski RA, Vaszar LT, Fenning K, Steiner J, de Bie E, Musigdilok VV, Altman DA, Dyer DS, Kelly K, Migliorett DL, Wiener RS, Slatore CG, Smith-Bindman R. Emotional distress, anxiety, and general health status in patients with small pulmonary nodules shortly after their identification: results from the Watch the Spot Trial. Chest. 2023 Dec;164(6):1560-1571. PMID: 37356710
Golden SE, Currier JJ, Ramalingam NP, Patzel M, Shannon J, Davis MM, Slatore CG. Primary care providers experiences performing low-dose computed tomography for lung cancer screening. J Am B Fam Med. 2024 Jan 5;36(6):952-965. PMID: 38092437
Núñez ER, Zhang S, Glickman ME, Qian SX, Boudreau JH, Lindenauer PK, Slatore CG, Miller DR, Caverly TJ, Wiener RS. What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening. Am J Respir Crit Care Med. 2024 Jan 15;209(2):197-205. PMID: 37819144.
Hayes S, Duan KI, Wai TH, Picazo F, Donovan LM, Spece LJ, Plumley R, Slatore CG, Thakur N, Crothers K, Au DH, Feemster LC. Association between neighborhood socioeconomic disadvantage and COPD prevalence among US Veterans. (Research Letter). Ann Am Thorac Soc. 2024 Jan 22. doi: 10.1513/AnnalsATS.202308-668RL. Online ahead of print. PMID: 38252425.
Slatore CG, Hooker ER, Shull S, Golden SE, Melzer AC. Association of patient and health care organization factors with incidental nodule guidelines adherence: a multi-system observational study. Lung Cancer. Available online 29 February 2024. PMID: 38452601.
Wisnivesky JP, Mudd J, Stone K, Slatore CG, Flores R, Swanson S, Blackstock W, Smith CB, Chidel M, Rosenzweig RK, Henschke C, Kern JA,. Longitudinal quality of life following sub-lobar resection and stereotactic body radiation therapy for early stage non-small cell lung cancer. Cancer. 2024 Mar 21. doi: 10.1002/cncr.35286. Online ahead of print. PMID: 38511395.
Moghanaki D, Taylor J, Bryan A, Vitzthum L, Sebastian N, Gutman D, Burns A, Huang Z, Lewis J, Spalluto L, Williams C, Sullivan D, Slatore CG, Behera M, Stokes W. Lung cancer survival trends in the Veterans Health Administration. Clinical Lung Cancer.2024 Mar 28. Online ahead of print.
Disher N, Scott J, Tyzik A, Golden SE, Baker G, Hynes DM, Slatore CG. Evaluation of survey delivery methods in a national study of Veterans’ healthcare preferences. Hlth Serv Outcomes Research Method. In press.
Disher N, Vranas KC, Golden SE, Slatore CG, Tuepker A, Nugent S. Findings from a qualitative study about ICU physicians’ wellbeing during the COVID-19 pandemic. Current Psychology. In press.

Reviews (Non-systematic) & Statements/Guidelines

Tilles SA, Slatore CG. Hypersensitivity reactions to non-beta lactam antibiotics. (Review). Clin Rev All Imm. 2003 Jun;24(3):221-8. PMID:12721393.
Slatore CG, Tilles SA. Sulfonamide hypersensitivity. (Review). Immunol Allergy Clin North Am. 2004 Aug;24(3):477-90. PMID:12721393.
Slatore CG. Book Review of Oxford Handbook of Acute Medicine. Respir Care. 2005 Sep;50(9):1253-1254.
Colt HG, Murgu S, Korst R, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3^rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. CHEST. 2013 May;143(5 suppl);e437S-e454s. PMID:23649451.
Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, Zakher B, Slatore CG. Screening for Lung Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Evidence Synthesis No. 105. AHRQ Publication No. 13-05196-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2013 July. PMID:24027793.
Hunnibell LS, Slatore CG, Ballard EA. Foundations for lung nodule management for nurse navigators. Clin J Oncol Nurs. 2013 Oct;17(5):525-31. PMID:24080051.
Smith MEB, Chiovaro J, O’Neil M, Kansagara D, Quinones A, Freeman M, Motu’apuaka M, Slatore CG. Early Warning Scoring Systems: A Systematic Review. VA-ESP Project #05-225;2014 Jan. PMID:25506953.
Kahn JM, Gould MK, Krishnan J, Wilson KC, Au DH, Cooke CR, Douglas IS, Feemster LC, Mularski RA, Slatore CG, Wiener RS. An Official American Thoracic Society Workshop Report: Developing Performance Measures from Clinical Practice Guidelines. Ann Am Thorac Soc. 2014 May;11(4):S186-95.
Slatore CG, Horeweg N, Jett JR, Midthun DE, Powell CA, Wiener RS, Wisnivesky JP, Gould MK. An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management. Am J Respir Crit Care Med. Am J Respir Crit Care Med. 2015 Aug 15;192(4):500-14. PMID:26278796
Wiener RS, Gould MK, Arenberg D, Au DH, Fenning K, Lamb CR, Mazzone P, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera P, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH. An Official American Thoracic Society Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs with Low-Dose Computed Tomography in Clinical Practice. Am J Respir Crit Care Med. 2015 October 1;192(7):881-891. PMID:26426785.
Wilson KC, Gould MK, Krishnan JA, Boyd CM, Brozek JL, Cooke CR, Douglas IS, Goodman RA, Joo MJ, Laureau S, Mularski RA, Patel MR, Rosenfeld RM, Shanawani H, Slatore CG, Sockrider M, Sufian E, Thompson CC, Wiener RS. An Official American Thoracic Society Workshop Report: A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Disease, Critical Illness, and Sleep Disorders. Ann Am Thorac Soc. 2016 Mar;13(3):S12-21. PMID:26963362.
Iaccarino JM, Slatore CG. Smoking Cessation: ATS Core Curriculum 2017: Part IV. Adult Pulmonary Medicine. Ann Am Thorac Soc. 2017 Aug;14(Supplement_2):S196-S208. PMID: 28857625. (Review)
Kathuria H, Detterbeck J, Fathi J, Fennig K, Gould MK, Jolicoeur D, Land SR, Massetti GM Mazzone PJ, Silvestri G, Slatore CG, Smith R, Vachani A, Zeliadt S, Wiener RS. Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1202-1212. PMID:29090963
Rivera MP, Tanner NT, Silvestri GA, Detterbeck FC, Tammemagi MD, Young RP, Slatore CG, Caverly TJ, Boyd CM, Braithwaite D, Fathi JT, Gould MK, Iaccarino JM, Malkoski SP, Mazzone PJ, Tanoue LT, Schoenborn NL, Zulueta JJ, Wiener RS, Tanner N. Incorporating chronic illness into decisions about patient selection for lung cancer screening: an official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 July 15;198(2):e3-13. PMID:30004250.
Zhang Z, Bergan R, Shannon J, Slatore CG, Bobe G, Takata Y. The role of cruciferous vegetables and isothiocyanates for lung cancer prevention: current status, challenges and future research directions. (Non-systematic Review). Mol Nutr Food Res.2018 Sep;62(18):e1700936. PMID:29663679.
Vranas KC, Slatore CG, Kerlin MP. Telemedicine coverage of intensive care units: a narrative review. Ann Am Thorac Soc. 2018 Nov;15(11):1256-1264. PMID: 30382786.
Zullig LL, Jazowski SA, Chawla N, Williams CD, Winksi D, Slatore CG, Clary A, Rasmussen KM, Ticknor LM, Kelley MJ. Summary of Veterans Health Administration cancer data sources. J Registry Management. 2019 Fall 46(3):76-83.
Wiener RS, Barker AM, Carter-Harris L, Caverly TJ, Crocker DA, Denietolis A, Doherty C, Fagerlin A, Gallagher-Seaman M, Gould MK, Han PKJ, Herbst AN, Fukunga MI, McCullough MB, Miano DA, Quaife SL, Slatore CG, Fix GM. Stakeholder research priorities to promote implementation of shared decision-making for lung cancer: an American Thoracic Society and Veterans Affairs Health Services Research and Development Statement. Am J Respir Crit Care Med. 2022 Mar;205(6):619-630. PMID: 32589730.
Barta JA, Jarjah F, Thomson CC, Dyer DS, Wiener RS, Slatore CG, Smith-Bindman R, Rosenthal LS, Silvestri GA, Smith RA, Gould MK. The American Cancer Society National Lung Cancer Roundtable Strategic Plan: Optimizing strategies for lung nodule evaluation and management. (Non-systematic Review). Cancer. In press.

Peer Reviewed – Non-Research (e.g. Case Reports)

Slatore CG, Yank V, Jewell KD, Fligner C. Bronchial-pulmonary artery fistula with fatal massive hemoptysis caused by anastomotic bronchial aspergillus infections in a lung transplant recipient. (Teaching Case). Respir Care. 2007 Nov;52(11):1542-5. PMID:17971258
Liew J, Stevens J, Slatore C. Refractory Hypoxemia in a Patient with Submassive Pulmonary Embolism and an Intracardiac Shunt: Case Report and Review of the Literature. (Case Report). Perm J. 2018 Mar 2;22. PMID:29616915.

Books

Chapters

Tanner NT, Gould MK, Slatore CG. Pulmonary Nodule (Book Chapter) in Murray & Nadel’s Textbook of Respiratory Medicine Seventh Edition. Editors: V. Courtney Broaddus, Joel D. Ernst, Talmadge E. King, Stephen C. Lazarus, Kathleen F. Sarmiento, Lynn M. Schnapp, Renee D. Stapleton, Michael B. Gotway. Elsevier. May 14, 2021.

Other Publications/Products (e.g. Letters, Editorials, Patient Education Materials)

Slatore C, Stuart S. Physician specialty board certification. JAMA. 2004 Dec 22; 292(24):2973-4 (letter to editor). PMID: 15613658.
Slatore CG, Lareau SC, Fahy B. American Thoracic Society Patient Information Series: Staging of Lung Cancer. Am J Respir Crit Care Med. 2010 Nov 1;182:P1-P2.
Slatore CG. Lung Cancer Prevention: 2010 Year of the Lung Patient Education Handout Series. Am J Respir Crit Care Med. 2010 Nov 15;182(10):P3.
Slatore CG, Wiener RS, Cooke CR. Reply to F. Vincent, et al and Reply to S. Alibhai re Intensive Care Unit Outcomes among Patients with Lung Cancer in the SEER-Medicare Registry. J Clin Oncol. 2012 Oct 5;30:3652-3653.
Drake MG, Slatore CG. American Thoracic Society Patient Information Series: Smoking Marijuana and the Lungs. Am J Respir Crit Care Med. 2013 Jun 1;187(11):P5-6
Wiener RS, Slatore CG. Framing discussions about CT screening for lung cancer so that patients see the whole picture. (Editorial). CHEST. 2013 Dec;144(6):1749-1750. PMID:24297116.
Humphrey L, Deffebach M, Pappas M, Slatore CG. Reply to J. Brodersen, et al and Reply to J. Brodersen, et al re Screening for Lung Cancer with Low-dose Computed Tomography. Ann Intern Med. 2014;160(3):212. PMID:24493448
Slatore CG, Lareau SC. American Thoracic Society Patient Information Series: Treatment of Lung Cancer. Am J Respir Crit Care Med. 2014;189:P1-3.
Lareau SC, Moseson EM, Slatore CG. American Thoracic Society Patient Information Series: Exacerbation of COPD. Am J Respir Crit Care Med. 2014;189:P11-12. PMID:24628325.
Wiener RS, Slatore CG. Real world evidence about potential psychosocial .harms of lung cancer screening. (Editorial). JAMA Int Med. 2014 Aug;174(8):1416. PMID:25090181.
Slatore CG, Sockrider M. American Thoracic Society Patient Information Series: Lung cancer prevention. Am J Respir Crit Care Med. 2014 Nov 1;190(10):P7-8. PMID:25398122
Cooke CR, Wiener RS, Slatore CG. Reply to M. Soares re Aggressiveness of intensive care use among patients with lung cancer in the SEER-Medicare registry. CHEST. 2015 Feb 1;147(2):e57. PMID:25644919
Slatore CG, Arenberg D, Wiener RS, Sockrider M. American Thoracic Society: Decision Aid for Lung Cancer Screening with Computerized Tomography. 2015 May 11. http://www.thoracic.org/patients/patient-resources/resources/decision-aid-lcs.pdf
Sullivan DR, Slatore CG. Advance Care Planning: Does it Benefit Surrogate Decision Makers in the Intensive Care Unit?" (Editorial). Ann Am Thorac Soc. 2015 Oct;12(10):1432-1433. PMID:26448348.
Slatore CG, Wiener RS, Laing AD. American Thoracic Society Patient Information Series: What is a Lung Nodule? Am J Respir Crit Care Med. 2016;193(7):P11-12.
Slatore CG, Kulkarni HS, Corn J, Sockrider M. Improving Health Literacy for patients with Respiratory, Sleep, and Crticial Illnesses: New American Thoracic Society Guidelines for Patient Education Materials. Ann Am Thorac Soc. 2016 Aug;13(8):1208-11. PMID:27509148.
Moghanaki D, Timmerman RD, Slatore CG, Niewoehner DE, Karas TZ. In Regard to Valle et al. (letter to editor).Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):482-3. PMID:27598815
Drake MG, Slatore CG. American Thoracic Society Patient Information Series: Smoking Marijuana and the Lungs. Am J Respir Crit Care Med. 2017 Feb 1;195(3):P5-6
Stone E. Slatore CG. The obesity paradox – what does it mean for lung cancer surgery (Editorial). J Thorac Oncol. 2017 Aug;12(8):1174-1176. PMID:28748811
American Thoracic Society and American Lung Association Lung Cancer Screening Implementation Guide. Editors: Thomson CC, McKee A. Contributor: Slatore CG. May 31, 2018.http://www.lung.org/assets/documents/lung-cancer/implementation-guide-for-lung.pdf.
Lareau SC, Moseson EM, Slatore CG. American Thoracic Society Patient Information Series: Exacerbation of COPD (Update). Am J Respir Crit Care Med. 2018 Dec 1;198(11):P21-22. PMID:30499702.
Slatore CG. Counterpoint: Can shared decision making of physicians and patients improve outcomes in lung cancer screening? No. Chest. 2019 Jul;156(1):15-17. PMID:31279362
Slatore CG. Counterpoint: Can shared decision making of physicians and patients improve outcomes in lung cancer screening? No. Rebuttal. CHEST. 2019 Jul;156(1):19-20. PMID:31279373.
Burks AC, Gould MK, Silvestri G, Yarmus LB, Sears CR, Arenberg DA, Gonzalez AV, Slatore CG, Tanner NT, Vachani A, Nana-Sinkam P, Fuster MM, Wahidi MM, Tanoue LT, Rivera MP. Safely and effectively evaluating CT detected lung lesions: much work to be done. (Perspective). Ann Am Thorac Society. 2019 Nov;16(11):1360-1362. PMID:31437410.
Sullivan DR, Slatore CG. Reply to Skelin, et al. re Early Palliative Care Utilization and Associations with Survival and Place of Death among Patients with Advanced Lung Cancer. JAMA Oncol. 2020 Jan 16. doi: 10.1001/jamaoncol.2019.6301. [Epub ahead of print] No abstract available. PMID:31944220.
Golden SE, Slatore CG. Reply to A, Braillon re: “I’m putting my trust in their hands”: a qualitative study of patients’ views on clinician initial communication about lung cancer screening. Chest. 2020 Oct;158(4):1796. PMID: 33036107.
Ito Fukunaga M, Wiener RS, Slatore CG. The 2021 US Preventive Services Task Force Recommendation on Lung Cancer Screening: The More Things Stay the Same…. JAMA Oncol. 2021 May 1;7(5):684-686. PMID: 33687430
Neff S, Drake MG, Slatore CG, Burnham E. American Thoracic Society Patient Information Series: Inhaled Marijuana and the Lungs. Am J Respir Crit Care Med. 2021 Sep; 204(5):P9-10.
Lewis JA, Wiener RS, Slatore CG, Spalluto LB. Doing Versus Documenting Shared Decision Making for Lung Cancer Screening-Are They the Same? J Am Coll Radiol. 2022 May 18:S1546-1440(22)00336-2. PMID: 35594952.
Slatore C, Lareau SC, Fahy B. Staging of Lung Cancer. Am J Respir Crit Care Med. 2022 May 1;205(9):P17-P19. PMID: 35486071
Rustagi AS, Slatore CG, Keyhani S. Self-rated health and ability to climb stairs: A pragmatic health assessment before lung cancer screening. (Ideas & Opinions). Ann Intern Med. Ann Intern Med . 2023 Mar 7 (online ahead of print). PMID: 36877963.
Golden SE, Unger S, Slatore CG. Establishing Telehealth Technologies within the VHA to Increase Smoking Cessation: Lessons Learned," to Fed Pract. 2023 Aug;40(8):256-260. PMID: 37868257
Hynes DM, Govier DJ, Niederhausen M, Tuepker A, Laliberte AZ, McCready H, Hickok A, Rowneki M, Waller D, Cordasco KM, Singer SJ, MdDonlad KM, Slatore CG, Thomas KC, Maciejewski M, Battaglia C, Perla L. Understanding care coordination for Veterans with complex care needs: protocol of a multiple-methods study to build evidence for an effectiveness and implementation study. Front Health Serv. 2023 Aug 15;3:1211577. PMID: 37654810

Electronic Publications/Products

Slatore CG, Krishnan JA. Podcast: ATS Research Statement on Comparative Effectiveness Research. AJRCCM. 2013 Nov 5. http://static.thoracic.org/podcast/AJRCCM-interviews/rccm-201310-1790ST…
Slatore CG, Mazzone P, Wiener RS. Podcast: 20 minutes on lung cancer screening; American Thoracic Society. 2015 Feb 12. http://www.thoracic.org/about/ats-podcasts/audios/lung-cancer-screening-implementation.php.
Slatore CG, Wiener RS, Rivera MP. Lung Cancer Screening Implementation: A Serial Discussion. (Podcast); American Thoracic Society. July 29, 2016. http://www.thoracic.org/about/ats-podcasts/lung-cancer-screening-implem…
Au DH, Slatore C, Mattox EA "Preventing acute exacerbations of COPD", presented by C. Slatore (April 2017). Pulmonary VA-ECHO 2017 Educational Series. VISN 20 SharePoint (restricted): http://vaww.visn20.portal.va.gov/sites/clinical/scanecho/pulmonary/Pres… Materials. CME distributed: 8.25 hours. File hits: 13 (as of 10/23/17).
Slatore CG, Lowy D. Role of the American Thoracic Society in the NCI Cancer Moonshot. (Podcast); American Thoracic Society. December 2017. http://www.thoracic.org/about/ats-podcasts/nci-role-in-supporting-lung-cancer-research.php
Slatore CG, Melzer A. Lung cancer screening is a process, not a scan” TheoryLab, American Cancer Society podcast. May 17, 2021. https://podcasts.apple.com/us/podcast/lung-cancer-screening-is-a-proces…

Submitted Publications

Schweiger L, Golden SE, Sullivan DR, Ilea I, Rice SPM, Melzer AC, Datta S, Davis JM, Slatore CG. Is lung cancer screening knowledge associated with patient-centered outcomes? A multi-institutional cohort study.
Sullivan DR, Golden SE, Schweiger L, Melzer AC, Datta S, Davis JM, Wiener RS, Slatore CG. Associations of Concordant and Shared lung cancer screening decision making with decisional conflict: a multi-Institution cohort study.
Boudreau J, Bolton R, Nunez E, Caverly T, Kearney L, Silwinski S, Herbst A, Slatore CG, Wiener RS. Veterans’ conceptualizations of lung cancer risk and impacts on conversations with clinicians: a qualitative study.
Golden SE, Young A, Warner S, Tuepker A, Lyons P, Sullivan DR, Slatore CG, Vranas K. Applying user-centered design to develop strategies to improve critical care delivery for patients with acute respiratory failure.
Slatore CG, Scott, JY, Hooker ER, Disher N, Golden SE, Govier D, Hynes DM. Motivators, barriers, and facilitators to choosing care in VA facilities vs community-based Veterans Affairs care.
Disher N, Vranas K, Golden SE, Slatore CG, Tuepker A, Nugent S. “Self-care went out the windows”: findings from a qualitative study about ICU physicians’ wellbeing during the COVID-19 pandemic.
Bolton R, Nunez ER. Boudreau J, Kearney LM, Sliwinski S, Herbst A, Slatore CG, Wiener RS. “We don’t get that information right back to us unless it’s a full-blown cancer”: challenges coordinating lung cancer screening across healthcare systems.
Sullivan DR, Dieckmann NF, Franklin H, Matlock DD, Coleman CA, Saha, S, Golden SE, Disher NG, Slatore CG, Vranas KC, Hayes S, Lee P, Mudambi L, Eden KB. Improving decision-making encounters in lung cancer treatment (iDECIDE): feasibility and acceptability of a low-literacy conversation tool.
Slatore CG, Golden SE, Schweiger L, Ilea I, Sullivan DR. Rice SPM, Wiener RS, Datta S, Davis JM, Melzer AC. Longitudinal assessment of communication with patient-reported outcomes during lung cancer screening.
Ritter TA, Timmerman RD, Hanfi HI, Shi H, Leiner MK, Feng H, Skinner VL, Robin LM, Odle C, Amador G, Sindowski T, Snodgrass AJ, Huang GD, Reda DJ, Slatore CG, Sears C, Cornwell LD, Karas T, Harpole DV, Palta J, Moghanaki D. Centralized quality assurance of stereotactic body radiation therapy for the Veterans Affair cooperative studies program Number 2005: A phase 3 randomized trial of lung cancer surgery or stereotactic radiotherapy for operable early-stage non-small cell lung cancer (VALOR)

Abstracts

Wighton TG, Friedli KJ, Slatore CG, Okikawa J, Jachinowski D, Rubsamen RM, Shapiro GG. Patient medication and lung function measurement compliance using an electronic asthma management system (abstract). J Allergy Clin Immunol. 1997;99(1):S71.
Slatore CG, Bryson CL, Au DH. Increased Glucose Levels with Inhaled Corticosteroids. Am J Respir Crit Care Med 2005;171:A128.
Mike LA, Lee J, Slatore CG, Chan LN. Reversible Hyperammonemia Syndrome and Encephalopathy Associated with L-Carnitine Deficiency after Bariatric Surgery for Weight Loss: A case report. Nutr Clin Pract. 2007.
Slatore CG, Littman AJ, White E. Lung Cancer: Association with Supplemental Multivitamin, Vitamin C and E, and Folate Intake. Am J Respir Crit Care Med 2007;175:A329
Slatore CG, Au DH, Hollingworth W. Cost Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer. Chest 2007;132(S):590S.
Slatore CG, Littman AJ, Au DH, Satia JA, White E. Lung Cancer: Association with NSAIDs in a Large Cohort. Abstract 3180. American Thoracic Society International Conference; May, 2008.
Slatore CG, Udris EM, Cecere LM, Moss, BR, Bryson CL, Au DH. Provider Communication among Patients with Chronic Obstructive Pulmonary Disease: Association with Patient Reported Outcomes. Abstract 4386. American Thoracic Society International Conference; May, 2009.
Slatore CG, Au DH, Gould MK. Insurance Status and Disparities in Outcomes of Lung Cancer Care: A Systematic Review. Abstract 4393. American Thoracic Society International Conference; May, 2009.
Cecere LM, Udris EM, Slatore CG, Au DH. The Effect of Obesity on Symptoms of Dyspnea, Health-Related Quality of Life, and Medication Use in Veterans with COPD. Abstract 3628. American Thoracic Society International Conference; May, 2009.
Reinke LF, Udris EM, Moss BR, Johnson MS, Slatore CG, Au DH. The Association of Depression and Preferences for Life-Sustaining Treatments in Veterans with COPD. American Thoracic Society International Conference; May 18, 2010; New Orleans, LA.
Zeliadt SB, Sekaran NK, Slatore CG, Au DH, Wu DY, Crawford J, Lyman GH, Dale DC. Comparison of Lung Cancer in the Veterans Affairs Oncology Registry and the SEER Cancer Registry. American Society of Clinical Oncology, June 5, 2010; Chicago, IL.
Brasky TM, Lampe JW, Slatore CG, White E. Long-term use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. American Association of Cancer Research Meeting, April 4, 2011; Orlando, FL.
Slatore CG, Gould MK, Au DH, Deffebach ME, White E. Lung Cancer and Stage at Diagnosis: Associations in the VITamins And Lifestyle (VITAL) Study. American Thoracic Society International Conference; May 15, 2011; Denver, CO.
Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. Factors Associated with Adherence to Long-Acting Inhaled Therapies Among Patients with COPD. American Thoracic Society International Conference; May 15, 2011; Denver, CO.
Reinke LF, Slatore CG, Uman J, Udris E, Moss BR, Engelberg RA, Au DH. Patient-clinician communication about end-of-life care topics. American Thoracic Society International Conference; May 16, 2011; Denver, CO.
Sullivan DR, Duckart JP, Slatore CG. Lung Cancer Outcomes Among Patients With Depression. American Thoracic Society International Conference; May 20, 2012; San Francisco, CA.
Slatore CG, Cecere LM, LeTourneau J, O’Neil ME, Duckart JP, Soylemez-Wiener R, Farjah F, Cooke CR. Intensive Care Unit Outcomes among Patients with Lung Cancer in the SEER-Medicare Registry. American Thoracic Society International Conference; May 20, 2012; San Francisco, CA.
Wiener RS, Gould MK, Slatore CG, Kneeland T, Hickey E, Welch HG, Schwartz L, Woloshin S. Evaluation of potentially malignant pulmonary nodules in the VA system: Resource use and adherence to guideline recommendations. Department of Veterans Affairs Health Services Research & Development National Conference; July 17, 2012.
Slatore CG, Au DH, Curtis JR, Press N, Wiener RS, Ganzini L. What The (Heck) Is A Nodule? A Qualitative Study Of Veterans' Reactions To Finding An Incidental Pulmonary Nodule. American Thoracic Society International Conference; May 19, 2013; Philadelphia, PA.
Sullivan DR, Duckart JP, Slatore CG. Chemotherapy Utilization In Advanced Non-Small Cell Lung Cancer Patients With Depression. American Thoracic Society International Conference; May 19, 2013; Philadelphia, PA.
Cooke CR, Feemster LC, Wiener RS, Slatore CG. Intensive Care Unit Utilization Among Patients With Lung Cancer In The SEER-Medicare Registry. American Thoracic Society International Conference; May 19, 2013; Philadelphia, PA.
Slatore CG, Golden SE, Wiener RS, Ganzini L, Au DH. Pulmonary nodule detection: association of patient-clinician communication with distress. American Thoracic Society International Conference; May 19, 2014.
Moseson EM, Golden SE, Slatore CG. Adherence to Fleischner Society guidelines among Veterans with pulmonary nodules in a clinical registry. American Thoracic Society International Conference; May 19, 2014.
Wiener RS, Slatore CG. Attitudes of VA pulmonologists towards implementation of low dose CT screening for lung cancer: results of a national survey. American Thoracic Society International Conference; May 19, 2014.
Sullivan DR, Pappas M, Humphrey L, Slatore CG. A systematic review of the psychosocial impact of lung cancer screening with computed tomography on patients. American Thoracic Society International Conference; May 21, 2014.
Golden SE, Wiener RS, Sullivan DR, Ganzini L, Slatore CG. Doctors know they don’t know: a qualitative study of primary care physicians caring for Veterans with incidental pulmonary nodules. Society of Clinical Research Associates Annual Conference; September 20, 2014.
Sullivan DR, Forsberg CW, Slatore CG. Longitudinal Association of Depression with Mortality Among Patients with Lung Cancer: A Cohort Study. American Thoracic Society International Conference; May 19, 2015.
Novosad S, Choi D, Hedberg K, Henkle E, Schafer S, Siegel SAR, Slatore CG, Winthrop KL. Predictors of Death at Isolation of Nontuberculous Mycobacteria in Respiratory Specimens. American Thoracic Society International Conference; May 19, 2015.
Wiener RS, Koppelman E, Slatore CG, Clark JA. Patients' Impressions of Communication with Their Clinicians Surrounding Low-Dose CT Lung Cancer Screening: A Qualitative Study. American Thoracic Society International Conference; May 20, 2015.
Sullivan DR, Golden SE, Ganzini L, Wiener RS, Slatore CG. Association of Actual and Preferred Decision-Making Roles with Patient-Reported Satisfaction and Quality of Medical Care Among Patients with Pulmonary. Nodules American Thoracic Society International Conference; May 15, 2016.
Golden SE, Thomas CR, Slatore CG. Even if I Don’t Remember I Feel Better: A Qualitative Study of Early Stage Non-Small Cell Lung Cancer Patients Undergoing Treatment. American Thoracic Society International Conference; May 15, 2016.
Crothers K, Kross E, Reisch LM, Shahris S, Slatore CG, Zeliadt S, Triplette M, Meza R, Elmore JG. Attitudes Regarding Lung Cancer Screening and Decision Aids: A Survey and Focus Group Study. American Thoracic Society International Conference; May 15, 2016.
Gesthalter YB, Koppelman E, Slatore CG, Kinsinger L, Yoon S, Cain H, Tanner NT, Au DG, Clark J, Wiener RS. Lessons Learned from Early-Adopting Lung Cancer Screening Programs: Staff Perspectives on Implementation. American Thoracic Society International Conference; May 15, 2016.
Tukey MH, Clark J, Bolton R, Slatore CG, Au DH, Wiener RS. Readiness for Implementation of CT Lung Cancer Screening Within a National Healthcare System. American Thoracic Society International Conference; May 15, 2016.
Iaccarino J, Simmons J, Slatore CG, Gould MK, Wiener RS. Availability of Resources and Processes of Care for Pulmonary Nodule Evaluation: A National Survey of American Thoracic Society Clinicians. American Thoracic Society International Conference; May 15, 2016.
Nugent SM, Thomas CR, Golden SE, Slatore CG. Self-efficacy and decisions in lung cancer: early stage lung cancer comparative effectiveness research consortium results. International Association for the Study of Lung Cancer Multidisciplinary Symposium in Thoracic Oncology; September 24, 2016.
Lammers A, Golden SE, Thakurta S, Mitin T, Thomas CR, Moghanaki D, Timmerman R, Slatore CG. Lung cancer specialists’ opinions for stage I NSCLC: a multidisciplinary survey. American Society for Radiation Oncology Annual Conference; September 25, 2016. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S172-S173. PMID: 27675703
Golden SE, Slatore CG, Thomas Jr CR. Information matters: a prospective qualitative study of clincians caring for patients with early stage non-small cell lung cancer. American Society for Radiation Oncology Annual Conference; September 26, 2016. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E408-E409. PMID: 27674610
Lammers AJ, Cetnar JP, Fromme EK, Slatore CG, Sullivan DR. Association of early specialist-delivered palliative care and chemotherapy receipt in patients with advanced stage lung cancer. OHSU Research Week. May 1, 2017.
Vranas KC, Scott JY, Badawi O, Joplin JK, Ramsey M, Harhay A, Milstein A, Liu X, Breslow M, Slatore CG, Kerlin MP. The association of admission to high-acuity versus low-acuity ICUs with outcomes to ICU patients at low risk of dying. American Thoracic Society International Conference; May 21, 2017.
Sullivan DR, Golden SE, Ganzini L, Hansen L, Lapidus J, Carney P, Slatore CG. Hospice utilization among advanced stage lung cancer patients in a national integrated health network. American Thoracic Society International Conference; May 22, 2017.
Triplette M, Kross EK, Mann B, Elmore JG, Slatore CG, Shahrir S, Frederick PD, Romine PE, Crothers KA. Assessing knowledge, barriers, and facilitators to lung cancer screening among primary care and pulmonary providers. American Thoracic Society International Conference; May 23, 2017.
Rankin NM, Slatore CG, Stone EC. Implementation science and challenges in lung cancer screening: a critical review of the literature. American Thoracic Society International Conference; May 23, 2017.
Zeliadt S, Birkby G, Eberth JM, Hoffman R, Park H, Trapi E, Brenner A, Reuland D, Slatore CG, Flocke SA. Early implementation of lung cancer screening across federally qualified health care centers in the U.S. American Thoracic Society International Conference; May 23, 2017.
Zeliadt S, Greene P Au DH, Krebs P, Klein D, Ko B, Swanson L, Todd K, Feemster LC, Reinke LF, Slatore CG, Heffner J. A controlled pilot trial of a proactive telephone outreach approach to integrating smoking cessation into delivery of lung cancer screening. American Thoracic Society International Conference; May 24, 2017.
Zeliadt S, Greene P, Krebs P, Klein D, Ko B, Swanson L, Todd K, Feemster LC, Slatore CG, Au DH, Reinke LF, Heffner J. Knowledge gaps and biased risk perceptions among current smokers participating in lung cancer screening. American Thoracic Society International Conference; May 24, 2017.
Caverly TJ, Wiener RS, Slatore CG, Lowery J, Fagerlin A. Comparison of observed harms and expected mortality benefit for veterans in VHA’s low-dose CT lung cancer screening demonstration project. VA HSRD National Meeting. July 2017
Heffner J, Krebs P, Johnson H, Greene P, Klein D, Feemster L, Slatore C, Au DH, Zeliadt S. Smokers’ expectations of the benefits of lung cancer screening and their associations with motivation to quit, treatment utilization, and short-term abstinence. Society for Research on Nicotine & Tobacco Annual Meeting. February 23, 2018.
Rinne S, Resnick K, Elwy R, Melzer AC, Prieto-Centurion V, Jones BE, Slatore CG, Wiener RS. Importance of Multidisciplinary Collaboration to Reduce COPD Readmissions in VA. American Thoracic Society International Conference. May 20^th 2018.
Sullivan DR, Forsberg CW, Golden SE, Ganzini L, Dobscha SK, Vranas KC, Slatore CG. Incidence of Suicide and Potential Benefits of Palliative Care Among Patients with Lung Cancer. American Thoracic Society International Conference. May 21^st, 2018.
Vranas KC, Myers T, Lin A, Zive D, Tolle S, Slatore CG, Sullivan DR. Association of Physician Orders for Life-Sustaining Treatment with Inpatient Healthcare Resource Utilization. American Thoracic Society International Conference. May 22^nd, 2018.
Nugent S, Golden SE, Ganzini L, Slatore CG, Zive D, Sullivan DR. POLST Utilization Among Veterans with Advanced-Stage Lung Cancer. American Thoracic Society International Conference. May 22^nd, 2018.
Melzer AC, Golden SE, Miranda L, Ono S, Slatore CG. “What Is Shared Decision Making?” A Qualitative Study of Clinician Communication in Lung Cancer Screening Programs. American Thoracic Society International Conference. May 22^nd, 2018.
Melzer AC, Golden SE, Miranda L, Ono S, Slatore CG. A Qualitative Study of Clinician Views of Lung Cancer Screening: The Role of Uncertainty. American Thoracic Society International Conference. May 22^nd, 2018.
Golden SE, Ono S, Thakurta S, Wiener RS, Melzer AC, Datta S, Slatore CG. “I Just Wanna Know”: A Qualitative Study of Patients Offered Lung Cancer Screening. American Thoracic Society International Conference. May 22^nd, 2018.
Golden SE, Ono S, Wiener RS, Melzer AC, Davis J, Slatore CG. Patient and Clinician Perspectives on Smoking Cessation in Three Lung Cancer Screening Programs. American Thoracic Society International Conference. May 22^nd, 2018.
Melzer AC, Wiener RS, Iaccarino JM, Slatore CG. The Association of Communication Characteristics and Risk Perception with Smoking Behaviors Among Patients with Incidentally Detected Pulmonary Nodules. American Thoracic Society International Conference. May 22^nd, 2018.
Golden SE, Howard M, Shull S, Forsberg CW, Hooker E, Crothers KA, Slatore CG. Validity of VHA Administrative Data to Determine Accurate Smoking Status. American Thoracic Society International Conference. May 22^nd, 2018.
Vranas KC, Scott JY, Slatore CG, Badawi O, Harhay MO, Sullivan DR, Kerlin MP. The Association of ICU Acuity with Adherence to Evidence-Based Practices Is Variable. American Thoracic Society International Conference. May 22^nd, 2018.
Lewis JA, Denton J, Matheny ME, Slatore CG, Maiga AW, Grogan E, Massion PP, Sherrier RH, Dittus RS, Keohane L, Roumie CL, Nikpay S. National lung cancer screening utilization trends in the Veterans Health Administration. Vanderbilt Implementation Science Symposium. May 6, 2019.
Spalluto LB, Lewis JA, Callaway-Lane C, Stolldorf D, Prusaczyk B, Limper H, Audet CM, Vogus T, Wiener R, Slatore C, Yankelevitz D, Henschke C, Dittus R, Massion PP, Lindsell C, Kripalani S, Moghanaki D, Roumie CL. Organizational Readiness for Lung Cancer Screening in the TN Valley Healthcare System. Implementation Research in the Learning Health System Symposium, Vanderbilt Center for Clinical Quality and Implementation Research. May 6, 2019
Vranas KC, Chan B, Slatore CG, Sullivan DR. The association of palliative care with indicators of quality cancer care among patients with advanced stage lung cancer. American Thoracic Society International Conference. May 19, 2019.
Sullivan DR, Ganzini L, Vranas KC, Slatore CG. Elements of specialist palliative care among patients with advanced stage lung cancer. American Thoracic Society International Conference. May 19, 2019.
Shenk JL, Vranas KC, Lin AL, Slatore CG, Sullivan DR. POLST-discordant care among patients presenting to the hospital: a qualitative analysis. American Thoracic Society International Conference. May 19, 2019.
Vranas K, Ouyang D, Lin A, Slatore C, Kerlin M, Liu K, Baron R, Calfee C, Ware L, Halpern S, Matthay M, Herridge M, Mehta S, Rogers A. Gender disparity in authorship of Critical Care Literature. American Thoracic Society International Conference. May 20, 2019.
Schweiger L, Golden SE, Melzer AC, Datta S, Slatore CG. Lung cancer screening: what you don’t know might not hurt. American Thoracic Society International Conference. May 21, 2019.
Lewis JA, Denton J, Matheny ME, Slatore CG, Maiga AW, Grogan E, Massion PP, Sherrier RH, Dittus RS, Keohane L, Roumie CL, Nikpay S. National lung cancer screening utilization trends in the Veterans Health Administration. American Society of Clinical Oncology Annual Meeting. June, 1 2019.
Spalluto LB, Lewis JA, Callaway-Lane C, Stolldorf D, Prusaczyk B, Limper H, Audet CM, Vogus T, Wiener R, Slatore C, Yankelevitz D, Henschke C, Dittus R, Massion PP, Lindsell C, Kripalani S, Moghanaki D, Roumie CL. Organizational Readiness for Lung Cancer Screening in a Veterans Affairs Healthcare System. International Association for the Study of Lung Cancer 2019 World Conference on Lung Cancer. Barcelona, Spain. September 9, 2019.
Sullivan DR, Schweiger L, Melzer AC, Datta S. Slatore CG. Lung cancer screening: associations of shared decision making and role concordance with patient-reported outcomes. Society for Medical Decision Making Annual Meeting. Portland, OR. October 20, 2019.
Nugent S, Sullivan DR, Thomas CR, Slatore CG. Patient-clinician communication and longitudinal patient-centered outcomes among stage I non-small cell lung cancer patients: A prospective cohort study. Society for Medical Decision Making Annual Meeting. Portland, OR. October 22, 2019.
Golden SE, Slatore CG. Differences in socio-economic resources among patients offered lung cancer screening. Society for Research on Nicotine and Tobacco. April 2020. Poster session canceled due to COVID-19.
DeSalvo J, Schweiger L, Melzer AC, Davis J, Slatore CG. Association of Lung Cancer Screening Communication and Smoking Cessation Readiness. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Vranas KC, Scott JY, Kerlin MP, Chesnutt MS, Sullivan DR, Slatore CG. Variability in Intensive Care Utilization Among Patients Admitted to VA Medical Centers with Acute Respiratory Failure. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Sullivan DR, Ganzini L, Delorit MA, Slatore CG, Golden SE, Vranas KC, Hansen L. Transcending Silos and Building Relationships: A Qualitative Study of Palliative Care Use and Integration in a National Health System. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Kern JA, Carr LL, Slatore CG, Farris M, Swanson S, Smith C, Stone K, Wisnivesky JP. Lung Function Changes Post Stereotactic Body Radiotherapy Treatment for Non-Small Cell Lung Cancer. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Hedstron G, Hooker ER, Howard M, Melzer AC, Wiener RS, Tanner NT, Iaccarino J, Slatore CG. Radiologists’ Adherence to Nodule Surveillance Guidelines in Two Health Care Systems. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Sullivan DR, Slatore CG, Stone K, Nugent SM, Kern J, Farris M, Roszenweig K, Swanson S, Wisnivesky JP. Associations Between Treatment and Team Composition with Decisional Regret Among Patients with Early Stage Lung Cancer. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Schweiger L, Tostado PR, Golden S, Melzer AC, Datta S, Sullivan DR, Slatore CG. Lung Cancer Screening: Association of Lung Cancer Susceptibility and Risk with Decisional Conflict and Distress. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Iaccarino J, Koppelman E, Slatore CG, Wiener RS. How Comorbidities Affect Patient Decision-Making for Lung Cancer Screening: A Qualitative Analysis. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19.
Nunez ER, Caverly T, Qian S, Boudreau, Slatore CG, Iaccarino J, Miller D, Wiener RS. Adherence to Lung-RADS Recommendations in a National Cohort of US Veterans Screened for Lung Cancer. American Thoracic Society International Conference. May 2020. Conference canceled due to COVID-19. Lung cancer screening and smoking cessation readiness: role of patient-clinician communication in differing types of lung cancer screen programs. CHEST Annual Meeting. October 2020. Virtual.
Nugent SM, Thomas CR, Sullivan DR, Slatore CG. Patient-clinician communication and longitudinal patient-centered outcomes among stage I non-small cell lung cancer patients: A prospective cohort study. Department of Radiation Oncology Research Retreat. November 7, 2020.
Slatore CG, Golden SE, Thomas T, Bumatay S, Shannon J, Davis M. “It’s really like any other study”: Practices of rural Oregon radiology facilities regarding performing low-dose computed tomography studies for lung cancer screening. North American Primary Care Research Group. November 24, 2020.
Young AB, Golden SE, Gundle KR, Slatore CG, Bailey SR. Smoking Cessation and Elective Surgery among Rural Veterans. Poster (virtual) presented at OHSU Research Week. May 2, 2022.
Núñez ER, Caverly TJ, Zhang S, Glickman ME, Qian SX, Boudreau JH, Slatore CG, Miller DR, Wiener RS. Timely Receipt of Guideline Recommended Annual Lung Cancer Screening Across Three Rounds Among US Veterans. American Thoracic Society International Conference. May 15, 2022.
Golden SE, Melzer AC, Tanner N, Deepak J, Slatore CG. Veterans Affairs partner perspectives on using a proactive teachable moment-based opt-out method to improve smoking cessation. American Thoracic Society International Conference. May 15, 2022
Vranas KC, Golden SE, Chapa J, Tuepker A, Sullivan DR, Slatore CG, Nugent S. A Qualitative Study of Physicians’ Perspectives on Communication and Therapeutic Relationships in the ICU during the COVID-19 Pandemic. American Thoracic Society International Conference. May 16, 2022.
Vranas KC, Gershengorn H, Ouyang D, Cheng S, Rogers AJ, Schweiger L, Cooke CR, Slatore CG. Influence of the COVID-19 Pandemic on Author Gender and Manuscript Acceptance Rates; American Thoracic Society International Conference. May 17, 2022.
Sullivan DR, Golden SE, Disher Ng, Vranas KC, Eden KB, Dieckmann NR, Slatore CG. "Give Us More of a Chance to Participate in Decision Making": A Qualitative Study Evaluating a Treatment Decision Support Tool and Patients' Decision Making Experiences. American Thoracic Society International Conference, May 17, 2022.
Gould MK, Creekmur B, deBie E, Kaplan C, Ritzwoller D, Steiner J, Golden S, Walter E, Mularski R, McEvoy R, Wiener R, Slatore C. Pulmonary Nodule-Related Emotional Distress 1-2 Months Following Nodule Identification in the Watch the Spot Trial. American Thoracic Society International Conference. May 18, 2022.
Wheeler M, Tammemagi M, Gould MK, Silvestri G, Slatore C, Bian J, Guo Y, Schabath M, Hochhegger B, Yang D, Karanth S, Zhang D, Braithwaite D. Survival differences by Charlson comorbidity index among early-stage NSCLC patients after stereotactic body radiotherapy. Society for Epidemiological Research 2022 Annual Meeting, June 16, 2022.
Nunez ER, Zhang S, Glickman ME, Qian X, Boudreau JH, Lindenauer PK, Slatore CG, Miller DR. Caverly TJ, Wiener RS. What makes someone too sick to screen? Factors associated with clinicians deeming patients inappropriate for lung cancer screening in the Veterans Health Administration. American Thoracic Society International Conference. May 21, 2023.
Vranas KC, Young A, Golden S, Tuepker A, Slatore CG. Utilizing a user-centered design approach in the development of an intensive care unit triage intervention for patients presenting to the emergency department with acute respiratory failure. American Thoracic Society International Conference. May 23, 2023.
Kearney L, Bolton, Nunez E, Boudreau J, Sliwiinski S, Herbst AN, Caverly T, Slatore CG, Wiener RS. Exploring provider conceptualization of limited life expectancy in the context of lung cancer screening: a qualitative study. American Thoracic Society International Conference. May 24, 2023.
Boudreau J, Bolton RE, Nunez ER, Kearney L, Sliwinski SK, Herbst AN, Caverly T, Slatore CG, Wiener RS. Veteran perceptions of lung cancer risk and implications for lung cancer screening programs. American Thoracic Society International Conference. May 24, 2023.
Wiener RS, Sliwinski S, Boudreau J, Herbst A, Nunez E, Kearney L, Caverly T, Slatore C, Bolton R. Organization of lung cancer screening programs and coordinator roles in Veterans Health Administration: Implications for quality of care. Academy Health. June 26, 2023.
Nahar R, Falvo MJ, Alexander T, Slatore C, Sotolongo AM. Initial HRCT findings and temporal changes of military Veterans evaluated for unexplained dyspnea at a VA national specialty clinic. CHEST Annual Meeting. October 8, 2023.
Nguyen RD, Cheng S, Chai M, Slatore CG, Naugler WE, Jou JH. Absence of pulmonary metastasis on chest CT in BCLC-A HCC. American Association for the Study of Liver Disease, Liver Meeting. November 12, 2023.
Singh R, Vranas KC, Lin AL, Slatore CG, Sullivan DR. Determining goal vs. POLST-discordant care among hospitalized patients: a qualitative study. Annual Assembly of Hospice and Palliative Care Conference. March 20-23, 2024.
Heintzman J, Hodes T, Lucas JA, Bailey SR, Bensken WP, Slatore CG, Banegas M, Marion M. Receipt of lung cancer screening among low-income Latinos, overall, and by foreign-born status. Advancing the Science of Cancer in Latinos. February 22, 2024.
Singh R, Vranas KC, Lin AL, Slatore CG, Sullivan DR. Determining goal vs. POLST-discordant care among hospitalized patients: a qualitative study. State of the Science in Hospice and Palliative Care - Annual Assembly of Hospice and Palliative Care Conference. March 23, 2024.

Invited Lectures, Conference Presentations or Professorships:

International and National

2010 American Thoracic Society, Sunrise Seminar; Lung Cancer and Chemoprevention: State of the Science (May 17, 2010; New Orleans, LA)

2010 ReachMD.com, Focus on Diabetes Series, Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression (podcast). (November 22, 2010, http://reachmd.com/xmsegment.aspx?sid=6093).

2012 American Thoracic Society, Scientific Symposium; Implementing Lung Cancer Screening: Moving from RCT’s to the Real World (May 22, 2012; San Francisco, CA)

2012 National Lung Cancer Partnership, From Bench to Bedside: Bringing Research Advances to the Clinic; Implementing Lung Cancer Screening in the Real World (June 1, 2012; Chicago, IL)

2012 HSR&D/QUERI National Conference, A comparative effectiveness study of pre-operative PET imaging and the reduction of unnecessary lung cancer surgery (July 18, 2012; Washington, DC)

2013 American Thoracic Society, Poster Discussion Session (Moderator); Dollars and Sense: Identifying the Costs, Utilization, and Burden of Respiratory Disease Management (May 19, 2013; Philadelphia, PA)

2014 Free to Breathe, Webinar; Understanding Lung Cancer Screening Guidelines (April 2, 2014)

2014 American Thoracic Society, Lung Cancer Screening Implementation Workshop; Implementation of Lung Cancer Screening (May 17, 2014; San Diego, CA)

2014 American Thoracic Society, Scientific Symposium; Implementation of Lung Cancer Screening: A Toolbox for Clinicians and Researchers (May 18, 2014; San Diego, CA)

2014 American Thoracic Society, Scientific Symposium; Defining the Relevant Quality Metrics for Lung Cancer Screening (May 18, 2014; San Diego, CA)

2014 American Thoracic Society, Scientific Symposium; Implementation of Lung Cancer Screening in the United States (May 19, 2014; San Diego, CA)

2014 American Thoracic Society, Poster Discussion Session (Moderator); Comparative Effectiveness: Treatments, Research, and Practice (May 19, 2014; San Diego, CA)

2014 American Thoracic Society, Outside Organization Session; Screening in the VA with Low Dose Chest CT Scans (May 21, 2014; San Diego, CA)

2014 Department of Veterans Affairs, Lung Cancer Screening Demonstration Project; Caring for Veterans with Pulmonary Nodules (November 18, 2014)

2015 American Thoracic Society, Outside Organization Session; Improving Communication Strategies in Patients Undergoing Screening with LDCT (May 17, 2015; Denver, CO)

2015 American Thoracic Society, Poster Discussion Session (Moderator); Effective Communication Strategies for Improvement of Patient Care (May 17, 2015; Denver, CO)

2015 American Thoracic Society, Scientific Symposium (Moderator); Controversies in Lung Cancer Screening: Pro/Con Debate (May 18, 2015; Denver, CO)

2015 American Thoracic Society, Scientific Symposium (Speaker); Screening Should Be Available at All Centers: PRO (May 18, 2015; Denver, CO),

2015 American Thoracic Society, Mini Symposium (Moderator); Lung Cancer Screening: Lessons Learned and Yet To Be Learned (May 20, 2015; Denver, CO)

2015 American Society for Radiation Oncology, Guest speaker; SBRT vs. Surgery for Patients with Early Stage Lung Cancer: An Observational Comparative Effectiveness Study (October 20-21, 2015; San Antonio, TX)

2016 Virginia Commonwealth University, Radiation Oncology Grand Rounds; Early Stage Lung Cancer: Difficult Decisions (April 6, 2016; Richmond, VA)

2016 American Thoracic Society, ATS Post-Graduate Seminar (Co-Chair & Speaker); Implementation of Core Components of a Lung Cancer Screening Program (May 13, 2016; San Francisco, CA)

2016 American Thoracic Society, ATS Official Workshop (Facilitator); Optimizing Smoking Cessation Interventions in Lung Cancer Screening Programs (May 14, 2016; San Francisco, CA)

2016 American Thoracic Society, Scientific Symposium (Speaker); Treatment of Early Stage and Screen-Detected Lung Cancer: A Pro/Con Debate (May 15, 2016; San Francisco, CA)

2016 American Thoracic Society, Poster Session (Moderator); Lung Cancer Screening and Nodule Evaluation (May 16, 2016; San Francisco, CA)

2016 American Thoracic Society, Mini-Symposium (Moderator); Beyond the NLST. (May 17, 2016; San Francisco, CA)

2016 American Thoracic Society, Scientific Symposium (Speaker); The Patient-Centered Juggernaut: The Right Move for Clinical Care, Policy, and Research?. (May 18, 2016; San Francisco, CA)

2016 National Academies of Sciences, Engineering, Medicine, National Cancer Policy Forum Workshop on Implementation of Lung Cancer Screening (Speaker); Lung Cancer Screening & Smoking Cessation: What do we know? .(June 20, 2016, Washington D.C.)

2017 American Thoracic Society, ATS Official Workshop (Speaker); Evaluation of Coexisting Chronic Illness in Selecting Patients for Lung Cancer Screening: A Research Agenda. (May 20, 2017; Washington, D.C.)

2017 American Thoracic Society, Pulmonary Clinical Core Curriculum (Speaker); Smoking Cessation, Electronic Cigarettes, and Other Adjuncts. (May 22, 2017; Washington, D.C.)

2017 American Thoracic Society, Mini-Symposium (Moderator); Lung Cancer Screening: Moving from Population to Person. (May 24, 2017; Washington, D.C.)

2017 International Early Lung Cancer Action Project, International Conference (Speaker); Update on Lung Cancer Screening at the VA Portland Health Care System. (September 15, 2017; Seattle, WA)

2018 VA-Partnership to Increase Access to Lung Screening (PALS), Lung Screening Summit; Current VA Screening Programs (Moderator); (January 25, 2018; Houston, TX)

2018 American Thoracic Society, ATS Post-Graduate Seminar The Nuts and Bolts of Qualitative Research: How to Do It Well in Research, Medical Education, and Quality Improvement (Speaker); Building Blocks: Qualitative Research Principles. (May 19, 2018; San Diego, CA)

2018 American Thoracic Society, ATS/ALA Implementation Guide for Lung Cancer Screening: An Operational Toolkit (Speaker); Patient Selection and Promoting Lung Cancer Screening among PCPs: Getting it Right. (May 20, 2018; San Diego, CA)

2018 American Thoracic Society, Scientific Symposium (Speaker). Lung Cancer Screening: Who’s In and Who’s Out? A Pro/Con Debate; LDCT Screening Patient Selection Should be Based on USPSTF Guideline Criteria. (May 21, 2018; San Diego, CA)

2018 Moffitt Cancer Center, Population Science, Research Conference (Speaker); Lung Cancer Screening: The Future is Over (September 18, 2018; Tampa, FL)

2018 University of Utah School of Medicine, Division of Pulmonary & Critical Care Medicine, Research Conference (Speaker); Lung Cancer Screening: The Future is Over (October 10, 2018; Salt Lake City, UT)

2018 Ichahn School of Medicine at Mount Sinai, Division of General Internal Medicine, Grand Rounds (Speaker); Lung Cancer Screening: The Future is Over (November 8, 2018; New York, NY)

2019 Duke University School of Medicine, Division of Pulmonary & Critical Care Medicine, Research Conference (Speaker); What we talk about when we talk about Lung Cancer Screening: Smoking Cessation? (April 30, 2019; Durham, NC)

2019 American Thoracic Society, Post-Graduate Course (Facilitator), Fundamentals of Writing Successful Mentored Clinical Research Grants (May 17, 2019; Dallas, TX.)

2019 American Thoracic Society, Mini-Symposium (Moderator), Reducing Disparities and Improving Outcomes in Lung Cancer Screening (May 19, 2019; Dallas, TX.)

2019 American Thoracic Society, Mini-Symposium (Moderator); Lung Cancer Screening: Novel Insights on Patient Selection and Outcomes (May 22, 2019; Dallas, TX.)

2019 Cleveland Clinic Foundation, Advances in Early Lung Cancer Detection Conference, (Speaker); USPSTF Guideline Development: A Fly on the Wall (September 26, 2019; Cleveland, OH)

2020 VA-Partnership to Increase Access to Lung Screening (PALS), Lung Screening Summit (Speaker); Lung Cancer Screening: Is it a Teachable Moment for Smoking Cessation? (January 30, 2020; Atlanta, GA)

2020 VA-Partnership to Increase Access to Lung Screening (PALS), Lung Screening Summit (Panelist); Screening Wisely (January 30, 2020 Atlanta, GA)

2020 American Thoracic Society, Scientific Symposium (Chair); Lung Cancer Screening: Something Old, Something New, Something Borrowed, Something Blue. (Conference cancelled due to COVID-19)

2020 Veterans Health Administration Innovation Experience 2020 Shark Tank (Speaker); VISN 20 Centralized Lung Cancer Screening Program. (October 28, 2020; Virtual)

2020 GO₂, Foundation, Centers of Excellence Summit, (Speaker); Communicating About Nodules: What Screening Patients Need to Hear and How. (October 29, 2020; Virtual)

2020 An Official ATS/VA HSR&D Research Statement: Promoting Research on Implementing Shared Decision-Making for Lung Cancer Screening, (Speaker); Measuring whether SDM has been implemented. (November 12, 2020; Virtual)

2020 Bristol Myers Squibb Foundation Virtual Grantee Summit, (Speaker); Lung Cancer Screening Implementation: Who knew that getting 7 million people into a CT scanner year after year would be so challenging. (November 18, 2020; Virtual)

2020 Bristol Myers Squibb Foundation Virtual Grantee Summit, (Panelist); Lung Cancer Screening Comprehensive Overview, Past, Present, Future. (November 18, 2020; Virtual)

2021 Department of Veterans Affairs, Radiation Oncology Webinar Series, (Speaker) Lung Cancer Screening Implementation: Complicated People Never Do What You Tell Them To (January 28, 2021; Virtual)

2021 Cleveland Clinic Foundation, Lung Cancer Education Day Grand Rounds, (Speaker) Lung Cancer Screening Implementation (October 13, 2021)

2021 GO₂, Foundation, Centers of Excellence Summit, (Panelist); Veterans Affairs Lung Cancer (October 14, 2021; Virtual)

2021 American Cancer Society, National Lung Cancer RoundTable Annual Meeting, (Speaker) Lung Precision Oncology Program Overview (December 6, 2021 ;Virtual)

2022 White House Cancer Cabinet Moonshot 2.0 (Speaker) Aiming for the Moon(shot): Accelerating Lung Cancer Care and Research https://www.youtube.com/watch?v=PJ0fv20sCPc (May 4, 2022; Virtual).

2022 American Thoracic Society, Special Session (Co-Chair); Lung Precision Oncology Program in VA: Risk Prediction Models and Biomarkers for Screening. (May 16, 2022; San Francisco, CA)

2022 Occidental College, Guest Lecturer; Envisioning and Enacting Health Justice (October 3, 2022). https://urldefense.com/v3/__https://drive.google.com/file/d/ 19Mlu8XELhsxhYJQbxZgtSuQ67-yhbS44/view?usp=sharing__;!!Mi0JBg!KqqKSngY-L7DGEKwe3GW1G_9RC7n_RlhQAS8mAqbHcljD9O7jqaWmFAYCWfL3txOJJqXSSx7vBvm9Z3cxh8$

2022 GO₂, Centers of Excellence Summit, (Speaker); Access, Equity, and Quality: Breaking the Cycle for Vulnerable Populations (November 1, 2022; Nashville, TN)

2023 University of Washington School of Medicine, Division of Pulmonary & Critical Care Medicine, Grand Rounds (Speaker); Patient-Clinician Communication Strategies: Patients with & at-risk for Lung Cancer (April 7, 2023; Seattle, WA (virtual))

2023 American Thoracic Society, Scientific Symposium (Speaker); Lung Cancer Screening: Harnessing the VA Enterprise to Expand Proven Early Detection Strategies. (May 22, 2023; Washington, DC)

2023 American Thoracic Society, Thematic Poster Session (Moderator); Sarcoma and neuroendocrine tumors: cases in thoracic oncology. (May 23, 2023; Washington, DC)

2023 American Cancer Society, Accelerating Lung Cancer Screening by Harnessing Information Technology and the Electronic Health Record (Speaker); Offering Systematic and Equitable Access to High-Quality Lung Cancer Screening. (October 2, 2023; Chicago, IL)

2023 Department of Veterans Affairs, National Center for Lung Cancer Screening (Speaker); Satellite Media Tour in support of Lung Cancer Screening Day. (October 25, 2023; Washington, DC) (https://app.criticalmention.com/cm/report/da313a76-7a18-43fc-aee7-60181384b546)

2023 American Cancer Society, Lung Cancer Screening Webinar for Veterans Affairs Health Systems (Speaker); Offering Systematic and Equitable Access to High-Quality Lung Cancer Screening. (November 14, 2023; virtual)

2024 VA Greater Los Angeles Health Care System, Department of Medicine Grand Rounds, (Speaker); Lung Cancer Screening Implementation: Why Not? (February 7, 2024, virtual)

Regional and Local

2008 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Lung Cancer Prevention and Detection: Understanding the Consequences (November 25, 2008)

2010 Grand Rounds, OHSU Division of Pulmonary and Critical Care Medicine; Pulmonary Hypertension at the VA: Is there a best practice? (May 7, 2010)

2011 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Lung Cancer Outcomes Research: Just Getting Started (September 26, 2011)

2011 Grand Rounds, OHSU Department of Medicine; Lung Cancer from Diagnosis to End-of-Life: A Pulmonologist’s Perspective (November 1, 2011)

2012 Grand Rounds, OHSU Division of Pulmonary and Critical Care Medicine; Update on Lung Cancer Screening: Era of Randomized Trials (January 6, 2012)

2012 Grand Rounds, OHSU Northwest Clinic for Voice and Swallowing; COPD: An Overview (March 9, 2012)

2012 Rubinstein Research Retreat; OHSU Department of Radiation Medicine; SBRT for NSCLC: CER & QOL (November 10, 2012)

2013 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; What the Heck is a Pulmonary Nodule? A Qualitative and Quantitative Analysis (April 15, 2013)

2014 Chest Disease Conference, Oregon Thoracic Society; Lung Cancer Screening: My Year of Living Semi-Dangerously (Feb 16, 2014)

2014 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Care of the Patient with Pulmonary Nodules: Room for Improvement... But How? (Feb 24, 2014)

2014 Grand Rounds, OHSU Division of Pulmonary and Critical Care Medicine; Lung Cancer Screening Implementation: Here we Go (Mar 7, 2014)

2014 Medical Staff Meeting, Portland VA Medical Center; What the Heck is a “nodule”? (Apr 17, 2014)

2014 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Patient-Centered Care: Discovering what we do well and what we might do better for patients with nodules (December 8, 2014)

2015 Grand Rounds, OHSU Division of Pulmonary and Critical Care Medicine; Lung Cancer Screening Implementation: Are we there yet? (Mar 13, 2015)

2015 Rubinstein Research Retreat; OHSU Department of Radiation Medicine; SBRT vs. Surgery for Patients with Early Stage Lung Cancer: An Observational Comparative Effectiveness Study (October 10, 2015)

2015 Fellows Research Seminar; OHSU Division of Hematology/Oncology; Pulmonary Nodule Evaluation: Process & Feelings (November 9, 2015)

2016 Cancer Prevention and Control Quarterly Meeting; OHSU Knight Cancer Institute; Pulmonary Nodules Don’t Equal Lung Cancer: What do Patients Want to Know and Hear? (May 11, 2016)

2016 Translational Oncology Program Monthly Meeting; OHSU Knight Cancer Institute; Personalized Medicine for Lung Cancer Decisions: Patient-Centered Communication (June 2, 2016)

2016 Medical Staff Meeting, VA Portland Health Care System; Update on the URF System (July 21, 2016)

2017 Horizon Initiative Symposium; OHSU Knight Cancer Institute; Communication about Pulmonary Nodules (March 14, 2017)

2018 Washington Thoracic Society Annual Chest Conference; American Lung Association; Lung Cancer & Health Disparities: Focusing on the Front Door (January 21, 2018)

2018 Washington Thoracic Society Annual Chest Conference; American Lung Association; Lung Cancer Panel Discussion (January 21, 2018)

2018 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Who knew communication about pulmonary nodules was so difficult? (Feb 12, 2018)

2018 Grand Rounds, OHSU Division of Pulmonary and Critical Care Medicine; Lung Cancer Screening: The Future is Over (September 14, 2018)

2018 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Lung Cancer Talk: Putting out the Smoke (Nov 5, 2018)

2019 Scientific Update and Strategic Planning, Cancer Control and Implementation Science, Knight Cancer Institute; Lung Cancer Screening Implementation: Key Informant Interview Study of Oregon’s Small and Rural Hospitals (March 5, 2019)

2019 Lung Force Expo, Washington American Lung Association; Lung Cancer Screening: How to do it and not do it (May 10, 2019)

2019 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Improving Health Care Delivery: Bedside to the World (September 23, 2019)

2020 Grand Rounds, OHSU Division of Pulmonary and Critical Care Medicine; Teachable Moments for Smoking Cessation in Pulmonary Medicine: Fact or Fiction (February 7, 2020)

2020 Research Conference, OHSU Division of Pulmonary and Critical Care Medicine; Lung Cancer Screening Implementation: Complicated People Never Do What You Tell Them To (December 14, 2020)

2021 Grand Rounds, Oncology Conference, Tuality Healthcare; Lung Cancer Screening: Evidence & Implementation Update (June 23, 2021)

2021 Grand Rounds, OHSU Department of Medicine; Lung Cancer Screening – Why Not? (November 23, 2021)

2023 Research Conference, OHSU Division of Pulmonary, Allergy, and Critical Care Medicine; (Speaker); Patient-Clinician Communication Strategies: Patients with & at-risk for Lung Cancer (May 31, 2023)

V. SERVICE

PROFESSIONAL ASSOCIATIONS

2006 - Present American Thoracic Society

2006 - 2016 American College of Chest Physicians

2015 - 2016 International Association for the Study of Lung Cancer

EDITORIAL RESPONSIBILITIES

2016 – 2022 Editorial Board Member, Annals of the American Thoracic Society

2019 – 2022 Editorial Board Member, Thoracic Oncology Editorial Board, CHEST

Ad Hoc Reviewer (in last five years) for Annals of Internal Medicine; American Journal of Respiratory and Critical Care Medicine; Annals of the American Thoracic Society; CHEST; JAMA; JAMA Oncology;

STUDY SECTIONS

3/2015 – 3/2020 American Lung Association Lung Cancer Discovery Research Award, Review Committee; Member

3/2017 – 3/2020 CHEST Foundation Research Grant in Lung Cancer, Review Committee; Member

2/2017 – 4/2017 National Institutes of Health, Special Emphasis Panel/Scientific Review Group 2017/05 ZRG1 PSE-U(O2) M, Review Committee; Ad Hoc Member

7/2020 – 3/2024 Veterans Health Administration Health Services Research & Development Career Development Award, Review Committee; Member

11/2021 – Present Knight Cancer Institute, Cancer Prevention and Control, Review Committee; Ad hoc Member

CURRENT LEADERSHIP POSITIONS

Listed on Page 2

PAST LEADERSHIP POSITIONS (outside formal committees)

Gender/Diversity Working Group, Co-Counselor

OHSU Division of Pulmonary & Critical Care Medicine 2016 – 2020

Center to Improve Veteran Involvement in Care, Director of Research Education (received 0.25 FTE)

VA Portland Health Care System 2019 - 2022

Unsuspected Radiologic Findings Registry, Medical Director (received 0.05 FTE)

VA Portland Health Care System 2012 - 2023

COMMITTEES (Leadership Positions in Bold)

Current

6/2015 – Present Patient Centered Outcomes Research Institute; Watch The Spot – Pragmatic Randomized Trial of Nodule Surveillance, PI Michael Gould, MD, MS; Steering Committee Member

1/2019 – Present Patient Centered Outcomes Research Institute; Comparing Smoking Interventions among Underserved Patients Referred for Lung Cancer Screening, PI Scott Halpern, MD. PhD; Data Safety Monitoring Board Member

7/2020 – Present American Cancer Society, National Lung Cancer Round Table, Lung Cancer Screening Implementation Strategies Task Group; Member

4/2022 – Present American College of Chest Physicians, CHEST Journal, Diversity, Equity, and Inclusion Workgroup; Member

5/2022 – Present American Thoracic Society, Thoracic Oncology Assembly; Assembly Committee Chair-Elect & Chair

5/2022 – Present American Thoracic Society, Thoracic Oncology Assembly Planning Committee; Member

5/2023 – Present Department of Veterans Affairs Veterans Health Administration, Office of Specialty Care Pulmonary Field Advisory Council; Member

1/2024 – Present American Cancer Society, Lung Cancer Screening Living Systematic Review, Technical Expert Panel; Member

1/2024 – Present American Cancer Society, Assessing Equity in Shared Decision Making, Utilization and Outcomes of Lung Cancer Screening, PI Jan Eberth, PhD; External Advisory Committee; Member

Past

International/National

5/2007 – 5/2013 American Thoracic Society, Behavioral Science & Health Services Research Assembly; Program Committee Member

5/2007 – 5/2011 American Thoracic Society, Project Committee: The Effects of Lack of Health Insurance; Member

5/2009 – 11/2013 American Thoracic Society, Project Committee: Assessing Impairment from Respiratory Disability; Member & Leader of Behavioral Science Group

9/2009 – 5/2013 American Thoracic Society, Project Committee: Patient Education & Lung Cancer; Member

3/2010 – 4/2014 American Thoracic Society, Patient and Family Education Committee; Member

3/2011 – 5/2013 American College of Chest Physicians, Diagnosis and Management of Lung Cancer: Evidence-based Clinical Practice Guidelines, 3^rd Edition; Member

4/2011 – 9/2013 United States Preventive Services Task Force, Committee on Lung Cancer Screening, Evidence Synthesis Program; Member

9/2011 – 5/2013 American Thoracic Society, Presidential Commission on Patient Involvement; Member

5/2012 – 4/2014 American Thoracic Society, Documents Development and Implementation Committee; Member

5/2012 – 5/2014 American Thoracic Society, Project Committee: Developing Performance Measures from ATS Guidelines; Member

1/2013 – 6/2015 American Thoracic Society, Project Committee: Evaluation of Pulmonary Nodules: An Agenda for Research and Implementation in Practice; Co-Chair

1/2013 – 5/2015 American Thoracic Society, Behavioral Science and Health Services Research Assembly Planning Committee; Member

5/2013 – 5/2016 American Thoracic Society, Thoracic Oncology Assembly Website Director

12/2013 – 10/2014 National Lung Cancer Partnership; Improving Access to Treatment for Lung Cancer Patients (AccessTLC) Advisory Committee, Member

12/2013 – 12/2013 National Cancer Institute; Mini-Think Tank for Lung Cancer Surveillance Advisory Committee, Member

4/2014 – 5/2017 American Thoracic Society, Patient and Family Education Committee; Chair

5/2014 – 5/2015 American Thoracic Society, Thoracic Oncology Assembly; Program Committee Member

5/2014 – 6/2016 American Thoracic Society, Thoracic Oncology Assembly; Planning Committee Member

5/2014 – 10/2015 American Thoracic Society, Project Committee: ATS Statement on Lung Cancer Screening Implementation; Committee Member

5/2014 – 12/2014 American Thoracic Society: ATS statement on the CMS lung cancer screening coverage decision; Committee Member

5/2014 – 6/2016 American Thoracic Society: Web Editorial Committee; Committee Member

10/2014 – 3/2016 American Thoracic Society, Project Committee: ATS Statement on Chronic Comorbid Conditions; Committee Member

5/2015 – 6/2016 American Thoracic Society: Behavioral Science and Health Services Research Assembly Nominating Committee; Member

5/2016 – 5/2018 American Thoracic Society, Thoracic Oncology Assembly; Program Committee Chair-Elect & Chair

5/2016 – 5/2017 American Thoracic Society, Project Committee: ATS Statement on Lung Cancer Screening and Tobacco Cessation; Committee Member

3/2017 – 5/2018 American Thoracic Society and American Lung Association, Lung Cancer Screening Playbook, Subgroup C Co-Chair

3/2017 – 7/2018 American Thoracic Society Project Committee: ATS Statement on Lung Cancer Screening and Comorbidities; Committee Member

8/2018 – 5/2019 American Thoracic Society Science and Innovation Committee; Committee Member

5/2019 – 5/2022 American Thoracic Society, Planning and Evaluation Committee; Member

4/2020 – 4/2023 Department of Veterans Affairs Veterans Health Administration, Office of Specialty Care Pulmonary Field Advisory Council; Member

Regional

4/49/2009 King County Public Health Disaster Planning: Health Decisions in Disasters: What to do if there's not enough; Member

Institutional (regional & national level institution service indicated in italics& bold, respectively)

3/2010 – 6/2012 OHSU/VAPORHCS Division of Pulmonary/Critical Care Medicine: Bronchoscopy Training Committee; Member

11/2010 – 2/2018 VAPORHCS Operative & Invasive Procedures Review Committee; Member

7/2010 – 6/2018 VAPORHCS Introduction to Pulmonary Clinic: Administrative Nuts & Bolts; created handout for trainees (annual update)

7/2011 – 6/2013 VISN20 Cancer Care Improvement Project; Member

9/2011 – 11/2013 VAPORHCS RCA Project; Member; Coordinated new NIPPV order set

7/8/2010 VAPORHCS Advanced Care Planning Focus Group; Participant

11/2011 – 12/2019 VAPORHCS Patient Education Committee; Ad Hoc Member

11/2011 – 9/2014 VISN 20 SCAN-ECHO Demonstration Project; Member & Site Lead (Allocated FTE)

2/2013 – 10/2015 VAPORHCS Lung Cancer Screening Clinical Demonstration Project; Site Co-Director (Allocated FTE)

2/2013 – 5/2017 Department of Veterans Affairs, National Center for Health Promotion and Disease Prevention (NCP), Lung Cancer Screening Clinical Demonstration Project (LCSCDP) Steering Committee; Member

7/2014 – 10/2014 VAPORHCS Unsuspected Radiologic Findings RCA Project; Member

10/2014 – 1/2021 VA-ECHO Planning Committee; Member

12/2016 – 5/2020 VAPORHCS, Institutional Review Board; Member (Allocated FTE)

3/2017 – 9/2017 Department of Veterans Affairs, Health Delivery Committee of the National Leadership Committee, Lung Cancer Screening Interdisciplinary Project Team; Member

11/2017 – 10/2018 VAPORHCS, Research Subject Recruitment Standard Operating Procedure Update Working Group; Lead

6/2020 – 12/2022 VISN 20 Centralized Lung Cancer Screening Program, 2020 Shark Tank Proposal Lead – Winner (top 2.5% of proposals)

7/2020 – 12/2022 Department of Veterans Affairs Veterans Health Administration, Lung Cancer Screening and Pulmonary Nodule National Standards Workgroup; Member

11/2020 – 4/2022 An Official ATS/VA HSR&D Research Statement: Promoting Research on Implementing Shared Decision-Making for Lung Cancer Screening, Member

12/2020 – 5/2022 Department of Veterans Affairs, National Lung Cancer Screening Tool, Integrated Project Team; Member

9/2022 – 6/2023 Veterans Health Administration Evidence Synthesis Program, “Non-Surgical Therapies vs. Surgery for Early Stage Non-Small Cell Lung Cancer in Medically Operable Individuals” Technical Expert Panel; Member

5/2023 – 9/2023 Oregon Health & Science, Knight Cancer Institute, Precision & Early Detection Strategic Planning Working Group; Member

Departmental

7/2003 – 6/2005 Division of Internal Medicine, University of Washington; Housestaff Committee; Member

10/2009 – 5/2010 VAPORHCS Pulmonary Hypertension Working Group; made suggestions to Section on Diagnosis & Treatment of Pulmonary Hypertension

3/2012 – 6/2017 OHSU PCCM T-32 Committee; Member

1/2017 – 12/2020 T32 Executive Committee Member; OHSU Division of Pulmonary & Critical Care Medicine

COMMUNITY SERVICE

CLINICAL RESPONSIBILITIES

~ 6-8 weeks/year of inpatient attending on VA Critical Care & Pulmonary Services
~ ½ day/month of VA Pulmonary Clinic
~ 2-3 weeks/year of VA Pulmonary Triage Service

VI. TEACHING

Teaching

2004 Inpatient Teaching Attending, University of Washington Internal Medicine Program: Providence Campus (7/04, 10/04, 2/05); Responsible for three talks per week to housestaff and medical students

2006 Morbidity & Mortality Conference Moderator, University of Washington Internal Medicine Program: Providence Campus (August 16, 2006)

2006 Internal Medicine Housestaff Lecture, University of Washington Internal Medicine Program: Providence Campus; Community Acquired Pneumonia (August 16, 2006)

2007 Weekly Respiratory/Critical Care Conference, University of Washington Division of Pulmonary and Critical Care Medicine; Lung Cancer Chemoprevention (June 21, 2007)

2007 HUBIO 541, Respiratory Course, University of Washington School of Medicine; Small Group Instructor (November 2007)

2008 Advanced Cardiac Life Support, University of Washington Department of Emergency Services; Small Group Instructor (March 28, 2008)

2008 Capstone Procedures Course, University of Washington School of Medicine; Small Group Instructor (June 4, 208)

2008 Seattle Medic One Paramedic Training, University of Washington/Harborview Medical Center; Physician Evaluator (June 11 & 18, 2008)

2008 Clinical Research Works in Progress, Summer Seminar, University of Washington Division of Pulmonary and Critical Care Medicine; Introduction to Databases and Statistical Packages (August 28, 2008)

2008 Dental Resident Lecture Series, University of Washington School of Dentistry; COPD – What a Dentist Needs to Know (September 15, 2008)

2008 Weekly Respiratory/Critical Care Conference, University of Washington Division of Pulmonary and Critical Care Medicine; Provider Communication & Patient Outcomes (December 11, 2008)

2009 Seattle Medic One Paramedic Training, University of Washington/Harborview Medical Center; Physician Evaluator (June 17, 2009)

2010 Medicine Noon Report, Portland VA Medical Center; (Attend approximately one time/month)

2010 Pulmonary Clinic Post-Clinic Conference, Portland VA Medical Center (Attend one to four times/month)

2010 Bronchoscopy Training, OHSU Division of Pulmonary and Critical Care Medicine; Bronchoscopy in the Immunocompromised Host (June 29, 2010)

2010 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (August 10, 2010)

2010 OHSU Internal Medicine Residency Noon Lecture, Portland VA Medical Center; COPD: An Overview (September 28, 2010)

2010 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; Spirometry Small Group (October 18, 2010)

2010 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (October 19, 2010)

2011 Bronchoscopy Training, OHSU DiviRsion of Pulmonary and Critical Care Medicine; Bronchoscopy in the Immunocompromised Host (June 28, 2011)

2011 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (July 20, 2011)

2011 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (October 17, 2011)

2011 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; Chronic Airflow Obstruction Small Group (October 18, 2011)

2011 OHSU Internal Medicine Residency Journal Club, OHSU Department of Medicine; Lung Cancer Screening (October 19, 2011)

2012 OHSU Internal Medicine Residency, OHSU Department of Medicine; Introduction to Pulmonary Function Tests (January 31, 2012)

2012 OHSU Internal Medicine Residency Noon Lecture, OHSU Department of Medicine; COPD Exacerbations (February 28, 2012)

2012 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (July 31, 2012)

2012 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (October 16, 2012)

2012 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; Chronic Airflow Obstruction Small Group (October 16, 2012)

2013 OHSU Internal Medicine Residency Noon Lecture, OHSU Department of Medicine; COPD Exacerbations (January 22, 2013)

2013 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (July 31, 2013)

2013 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (October 22, 2013)

2013 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; Chronic Airflow Obstruction Small Group (October 22, 2013)

2014 OHSU Internal Medicine Residency Noon Lecture, OHSU Department of Medicine; Pneumonia (Team-Based Learning) (February 25, 2014)

2014 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (October 6, 2014)

2014 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; Chronic Airflow Obstruction Small Group (October 7, 2014)

2015 OHSU Internal Medicine Residency, OHSU Department of Medicine; Introduction to Pulmonary Function Tests (March 6, 2015)

2015 OHSU Internal Medicine Residency, OHSU Department of Medicine; ACP Review of Critical Care Medicine, Part 1 (April 1, 2015)

2015 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (April 20, 2015)

2015 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (July 23, 2015)

2015 OHSU Internal Medicine Residency Noon Lecture, OHSU Department of Medicine; Pneumonia (Team-Based Learning) (August 4, 2015)

2016 OHSU Division of Physician Assistant Education, OHSU School of Medicine; What is a PE and why should you care (January 26, 2016)

2016 OHSU Cancer Intersessions for 2^nd Year Medical Students, OHSU School of Medicine; Lung Cancer Screening: An Overview (February 24, 2016)

2016 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (March 17, 2016)

2016 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (July 28, 2016)

2016 OHSU Internal Medicine Residency OHSU Department of Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (December 20, 2016)

2017 OHSU Division of Physician Assistant Education, OHSU School of Medicine; What is a PE and why should you care (January 31, 2017)

2017 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (April 27, 2017)

2017 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Mechanical Ventilation Liberation (August 17, 2017)

2017 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (August 23, 2017)

2017 OHSU Internal Medicine Residency OHSU Department of Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (November 28, 2017)

2018 OHSU Division of Physician Assistant Education, OHSU School of Medicine; What is a PE and why should you care (January 31, 2018)

2018 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (April 26, 2018)

2018 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (August 2, 2018)

2019 OHSU Division of Physician Assistant Education, OHSU School of Medicine; What is a PE and why should you care (January 30, 2019)

2019 OHSU Internal Medicine Residency OHSU Department of Medicine; Common Questions, Quandaries, and Controversies in VTE Disease (February 19, 2019)

2019 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview (April 25, 2019)

2019 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Mechanical Ventilation Liberation (August 24, 2019)

2020 OHSU Division of Physician Assistant Education, OHSU School of Medicine; What is a PE and why should you care (January 28, 2020)

2020 OHSU Circulation Course for 2^nd Year Medical Students, OHSU School of Medicine; COPD: An Overview – In-person session cancelled due to COVID-19 pandemic

2020 Fellows Core Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; Mechanical Ventilation Liberation (July 10, 2020)

2022 Fellows Mini-Sabbatical Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; How to Choose a Mentor (January 12, 2022)

2023 Fellows Mini-Sabbatical Lecture Series, OHSU Division of Pulmonary and Critical Care Medicine; How to Choose a Mentor (January 11, 2023)

Curriculum Development

3/2010 – 7/2012 OHSU/VAPORHCS Division of Pulmonary/Critical Care Medicine: Bronchoscopy Training Curriculum

10/2013 – 2/2014 OHSU Department of Internal Medicine

Team-Based Learning Curriculum

6/2014 – Present OHSU/VAPORHCS Division of Pulmonary/Critical Care Medicine; T32 Fellowship Training Program

Course Chair: Introduction to Pulmonary/Critical Care Research Topics

9//2018 – 10/2021 OHSU/VAPORHCS Division of Pulmonary/Critical Care Medicine; Research in Progress – Clinical Investigators Targeting Excellence (RIP-CITE); Workgroup Lead

Personal Statement on Mentorship

I strongly value the role of mentorship in my career. I aim to foster an environment that rewards diligence, critical-thinking, advanced analytic skills, and strong writing with career success for my mentees. Importantly, there is good evidence that diversity and providing safe and inclusive training experiences for mentees is associated with better scientific output, rigor, and reproducibility. Thus, I am fully committed to increasing diversity and promoting safe and inclusive experiences to help produce high-quality research.

Mentorship Committees/Leadership Positions

7/2017 – 1/2021 T32 Executive Committee Member; OHSU Division of Pulmonary and Critical Care Medicine

12/2019 – 10/2022 Director of Research Education; Center to Improve Veteran Involvement in Care at VA Portland Health Care System

12/2019 – 6/2022 Member; Mentorship Academy, OHSU School of Medicine

1/2021 – Present T32 Co-Director; OHSU Division of Pulmonary and Critical Care Medicine

Mentorship Education/Seminars

6/2015 – 6/2016 Mentored Training in Dissemination & Implementation Research in Cancer, Washington University in St. Louis; sponsored by the National Cancer Institute (1 R25 CA171994-01A1)

12/2019 OHSU School of Medicine and Portland State University Center for Improvement of Mentored Experiences in Research; Workshop Participant

11/2023 OHSU School of Medicine Mentorship Academy Culturally Aware Mentoring (CAM) Workshop; Participant

Individual Mentoring and Advising

Note: Bold indicates academic- or research-affiliated career position during or after research mentorship

Research Mentoring

7/2011 – 8/2020 Research Mentor for Donald Sullivan, MD MA MCR (PCCM Fellow; Current: Associate Professor OHSU);

Awarded PCCM T32: 7/12-6/13; Primary Mentor; Funding for 1.0 FTE
Awarded OHSU KL2: 7/14-6/16; Secondary Mentor; Funding for 0.75 FTE
Awarded NCI K07: 9/15-8/20; Secondary Mentor; Funding for 0.75 FTE

7/2013 – 6/2015 Research Mentor for Erika Moseson, MD MA (PCCM Fellow; Current: Private Practice); 10hrs/month

3/2014 – 6/2015 Research Mentor for Stephanie Mittelstaedt, MD MPH (Internal Medicine Resident; Current: Private Practice); 2hrs/month

6/2014 – 6/2015 Thesis Committee Member for Shannon Novosad, MD MPH (PCCM Fellow)

Awarded PCCM T32: 7/14-6/15; Secondary Mentor; Funding for 1.0 FTE
Lieutenant Commander, US Public Health Service; Medical Officer, US Centers for Disease Control & Prevention: Started 7/2015.

8/2015 – Present Research Mentor for Kelly Vranas, MD (PCCM Fellow; Current: Associate Professor OHSU); 2-5 hrs/month

Awarded PCCM T32: 9/15-8/17; Funding for 1.0 FTE
Awarded OHSU K12: 7/17-6/19; Primary Mentor; Funding for 0.75 FTE
Awarded Dept. of Veterans Affairs, HSRD Career Development Award: 7/20-6/24; Funding for 0.75 FTE

8/2015 – 5/2018 Research Mentor for Austin Lammers, MD (Oncology Fellow; Current: Private Practice); 5 hrs/month

Awarded Tartar Research Fellowship

8/2016 – Present Research Mentor for Shannon Nugent, PhD (HSRD Fellow; Current: CIVIC Investigator); 2-5 hrs/month

CIVIC investigator; Funding for 1.0 FTE
Awarded American Cancer Society Career Development Award: 1/2019-12/2023; Primary Mentor; Funding for 0.75 FTE

8/2016 – 12/2020 Dissertation Committee Member & Research Mentor for Sara Golden, MPH, PhD Portland State University; 5-10 hrs/month

5/2017 – 12/2020 Research Mentor for Jonathan Iaccarino, MD MS (Assistant Professor, Boston University); 1 hr/month

NCI K08 2^nd submission with Intent to Fund but declined
Assistant Professor, Boston University; 7/2021

7/2018 – 8/2022 Research Mentor for Liana Schweiger, MD (PCCM Fellow); 5-10 hrs/month

ATS TOA Abstract Scholarship; 2019 International Conference
Awarded VA HSRD Fellowship: 8/20 – 7/22; Funding for 1.0 FTE
Awarded Tartar Trust: 9/2020
Assistant Professor, OHSU: 8/22 - Present

7/2019 – Present Research Mentor for Reid Thompson, MD PhD (Radiation Oncology Assistant Professor); 2 hrs/month

Awarded Dept. of Veterans Affairs, CSRD Career Development Award: 7/19-6/24; Secondary Mentor; Funding for 0.75 FTE

7/2019 – 6/2021 Research Mentor for Grady Hedstrom, MD (PCCM Fellow); 5 hrs/month

7/2019 – 6/2021 Research Mentor for Janel DeSalvo, MD (Internal Medicine Resident); 5 hrs/month

7/2019 – 7/2022 Research mentor for Jennifer Lewis, MD (Assistant Professor, Vanderbilt University Medical Center); 2 hrs/month

11/2019 – 8/2020 Research Mentor for Nina Akbar, MD (Infectious Diseases; HSRD Fellow; Current Private Practice); 5 hrs/month

2/2023 – 5/2023 Research Mentor for Ikram Ade (undergraduate, CIVIC Internship Program; Planned short-term research project); 5 hrs/month

9/2023 – Present Research Mentor for Alison Rustagi, MD PhD (Assistant Professor, U. California San Francisco); 2 hrs/month

Awarded Dept. of Veterans Affairs, VISN21 Career Development Award: 10/23 – 9/25; Secondary Mentor; Funding for 0.75 FTE

Clinical Mentoring

4/2010 – 6/2010 Clinic Preceptor for Jaclyn Gadbois (1^st year Medical Student)

7/2010 – 6/2011 Clinical Fellowship Mentor for Vikas Grover, MD MPH (Critical Care Fellow)

3/2011 – 6/2011 Clinic Preceptor for Autumn Metzger (1^st year Medical Student)

3/2012 – 6/2012 Clinic Preceptor for Josha Woodward (1^st year Medical Student)

3/2014 – 6/2014 Clinic Preceptor for Amanda Ng (1^st year Medical Student)

1/2017 – 6/2017 Senior Author for Case Report written by Jean Liew, MD (3^rd year Resident)

7/2017 – 6/2019 Clinical Fellowship Mentor for Dubier Matos, MD (Critical Care Fellow)

Educational Leadership and Administration

10/2014 – 6/2017 OHSU Internal Medicine Residency Curriculum Committee; Member

Learner Assessment

Honors and Awards for Education

Departmental

Institutional

2005 Outstanding Teacher Award; Swedish Medical Center – Providence

2012 Faculty Teaching Award; Oregon Health & Science University, Department of Medicine Residency Program

2013 Chief Residents’ Award; Oregon Health & Science University, Department of Medicine Residency Program

2018 Faculty Teaching Award; Oregon Health & Science University, Department of Medicine Residency Program

Regional/National

School of Medicine Pulmonary, Allergy and Critical Care Medicine

Pulmonary, Allergy and Critical Care Medicine

Dr. Chris Slatore CV